General
~ Genetics of Breast & Ovarian Cancer

This category includes, but is not limited to: Reviews and general discussions, usually covering multiple subject areas from the other breast/ovarian cancer categories; articles of a general nature intended for wider public audience; overview or review articles for a specific medical specialty (such as nurses, radiologists, etc.); papers on a general topic wider than just HBOC, but covering HBOC topic(s) in reasonable detail; etc. Some of the references in this category are included in the other, specific subcategories, others are not, depending upon the depth to which they cover the topic of the subcategory.

List was last updated on Nov 30, 2019 @ 3:09 pm.


    • BRCA1/BRCA2 Pathogenic Variant Breast Cancer: Treatment and Prevention Strategies.
    • Lee A, Moon BI, Kim TH.
    • Ann Lab Med. 2020 Mar;40(2):114-121. doi: 10.3343/alm.2020.40.2.114.
    • Review

    Introductory article:

    From Genetic Testing to Treatment and Prevention of BRCA-Related Breast Cancer.

    • Hereditary Cancer Syndromes and Risk Assessment: ACOG COMMITTEE OPINION, Number 793.
    • [No authors listed]
    • Obstet Gynecol. 2019 Dec;134(6):e143-e149. doi: 10.1097/AOG.0000000000003562.

    Summary:

    Hereditary Cancer Syndromes and Risk Assessment: ACOG COMMITTEE OPINION SUMMARY, Number 793.

    • The OncoLifeS data-biobank for oncology: a comprehensive repository of clinical data, biological samples, and the patient's perspective.
    • Sidorenkov G, Nagel J, Meijer C, Duker JJ, Groen HJM, Halmos GB, Oonk MHM, Oostergo RJ, van der Vegt B, Witjes MJH, Nijland M, Havenga K, Maduro JH, Gietema JA, de Bock GH.
    • J Transl Med. 2019 Nov 14;17(1):374. doi: 10.1186/s12967-019-2122-x.
    • Hereditary prostate cancer - Primetime for genetic testing?
    • Heidegger I, Tsaur I, Borgmann H, Surcel C, Kretschmer A, Mathieu R, Visschere P, Valerio M, van den Bergh RCN, Ost P, Tilki D, Gandaglia G, Ploussard G; EAU-YAU Prostate Cancer Working Party.
    • Cancer Treat Rev. 2019 Nov 11;81:101927. doi: 10.1016/j.ctrv.2019.101927. [Epub ahead of print]
    • Review
    • [What attitude to women at high risk of breast cancer?]
    • Livon D, Moretta J, Noguès C.
    • Presse Med. 2019 Nov 6. pii: S0755-4982(19)30302-1. doi: 10.1016/j.lpm.2019.07.014. [Epub ahead of print]
    • Review, [Article in French]
    • New Consumer Podcast Highlights Steps Individuals Can Take to Understand Cancer Risk.
    • [No author given]
    • NSGC blog, 2019 Oct 29.

    Podcast: Genetic Counselors and You — Breast Cancer Awareness Month. (NSGC "Genetic Counselors & You" Podcast Series)

    • Genetic and Genomic Advances in Breast Cancer Diagnosis and Treatment.
    • Walker-Smith TL, Peck J.
    • Nurs Womens Health. 2019 Oct 25. pii: S1751-4851(19)30188-6. doi: 10.1016/j.nwh.2019.09.003. [Epub ahead of print]
    • Review
    • Cases in Precision Medicine: The Role of Tumor and Germline Genetic Testing in Breast Cancer Management.
    • Tischler J, Crew KD, Chung WK.
    • Ann Intern Med. 2019 Oct 22. doi: 10.7326/M18-2417. [Epub ahead of print]
    • Review
    • Landscape of Germline Mutations in DNA Repair Genes for Breast Cancer in Latin America: Opportunities for PARP-Like Inhibitors and Immunotherapy.
    • Urbina-Jara LK, Rojas-Martinez A, Martinez-Ledesma E, Aguilar D, Villarreal-Garza C, Ortiz-Lopez R.
    • Genes (Basel). 2019 Oct 10;10(10). pii: E786. doi: 10.3390/genes10100786.
    • Cancer Genetic Counseling—Current Practice and Future Challenges.
    • Schienda J, Stopfer J.
    • Cold Spring Harb Perspect Med. 2019 Sep 23. pii: a036541. doi: 10.1101/cshperspect.a036541. [Epub ahead of print]
    • Review
    • Breast cancer.
    • Harbeck N, Penault-Llorca F, Cortes J, Gnant M, Houssami N, Poortmans P, Ruddy K, Tsang J, Cardoso F.
    • Nat Rev Dis Primers. 2019 Sep 23;5(1):66. doi: 10.1038/s41572-019-0111-2.
    • Review
    • Li-Fraumeni syndrome: not a straightforward diagnosis anymore-the interpretation of pathogenic variants of low allele frequency and the differences between germline PVs, mosaicism, and clonal hematopoiesis.
    • Batalini F, Peacock EG, Stobie L, Robertson A, Garber J, Weitzel JN, Tung NM.
    • Breast Cancer Res. 2019 Sep 18;21(1):107. doi: 10.1186/s13058-019-1193-1.
    • Breast Cancer Screening in BRCA Mutation Carriers: Necessity of a Relevant Update of Mammographic Modalities.
    • Colin C, Doutriaux-Dumoulin I.
    • Radiology. 2019 Sep 3:191306. doi: 10.1148/radiol.2019191306. [Epub ahead of print]
    • Letter, Comment

    Original research:

    BRCA Mutation Carriers: Breast and Ovarian Cancer Screening Guidelines and Imaging Considerations.

    • Cancer: more genetic BRCA testing for men.
    • Marabelli M, Calvello M, Bonanni B.
    • Nature. 2019 Sep;573(7774):346. doi: 10.1038/d41586-019-02775-2.

    Commentary:

    New name for breast-cancer syndrome could help to save lives.

    • DNA Damage and Hormone Related Cancer: a repair pathway view.
    • Pooley KA, Dunning AM.
    • Hum Mol Genet. 2019 Aug 22. pii: ddz206. doi: 10.1093/hmg/ddz206. [Epub ahead of print]
    • Review
    • Application of Economic Evaluation to Assess Feasibility for Reimbursement of Genomic Testing as Part of Personalized Medicine Interventions.
    • Simeonidis S, Koutsilieri S, Vozikis A, Cooper DN, Mitropoulou C, Patrinos GP.
    • Front Pharmacol. 2019 Aug 2;10:830. doi: 10.3389/fphar.2019.00830. eCollection 2019.
    • The role of BRCA1/2 in hereditary and familial breast and ovarian cancers.
    • Hawsawi YM, Al-Numair NS, Sobahy TM, Al-Ajmi AM, Al-Harbi RM, Baghdadi MA, Oyouni AA, Alamer OM.
    • Mol Genet Genomic Med. 2019 Jul 17:e879. doi: 10.1002/mgg3.879. [Epub ahead of print]
    • Practical Cancer Genetics and Genomics in Women's Health.
    • Modesitt S, Pederson HJ, Adkins RT.
    • Clin Obstet Gynecol. 2019 Jul 11. doi: 10.1097/GRF.0000000000000480. [Epub ahead of print]
    • Review
    • How do mutations affecting the breast cancer genes BRCA1 and BRCA2 cause cancer susceptibility?
    • Venkitaraman AR.
    • DNA Repair (Amst). 2019 Jul 8:102668. doi: 10.1016/j.dnarep.2019.102668. [Epub ahead of print]
    • Review
    • [Hereditary Breast and Ovarian Cancer Syndrome].
    • Inuzuka M, Nakamura S.
    • Gan To Kagaku Ryoho. 2019 Jul;46(7):1109-1113.
    • Review, [Article in Japanese]
    • Lessons learned from two decades of BRCA1 and BRCA2 genetic testing: the evolution of data sharing and variant classification.
    • Toland AE, Brody LC; BIC Steering Committee.
    • Genet Med. 2019 Jul;21(7):1476-1480. doi: 10.1038/s41436-018-0370-4. Epub 2018 Nov 26.
    • Review
    • New name for breast-cancer syndrome could help to save lives.
    • Pritchard CC.
    • Nature. 2019 Jul;571(7763):27-29. doi: 10.1038/d41586-019-02015-7.

    Letter:

    Cancer: more genetic BRCA testing for men.

    Press: New Name of 'King Syndrome' for Hereditary BRCA Mutations. (Medscape Oncology)

    • Critical questions in ovarian cancer research and treatment: Report of an American Association for Cancer Research Special Conference.
    • Bast RC Jr, Matulonis UA, Sood AK, Ahmed AA, Amobi AE, Balkwill FR, Wielgos-Bonvallet M, Bowtell DDL, Brenton JD, Brugge JS, Coleman RL, Draetta GF, Doberstein K, Drapkin RI, Eckert MA, Edwards RP, Elias KM, Ennis D, Futreal A, Gershenson DM, Greenberg RA, Huntsman DG, Ji JXY, Kohn EC, Iavarone C, Lengyel ER, Levine DA, Lord CJ1, Lu Z, Mills GB, Modugno F, Nelson BH, Odunsi K, Pilsworth JA, Rottapel RK, Powell DJ Jr, Shen L, Shih IM, Spriggs DR, Walton J, Zhang K, Zhang R, Zou L.
    • Cancer. 2019 Jun 15;125(12):1963-1972. doi: 10.1002/cncr.32004. Epub 2019 Mar 5.
    • Conference report, Commentary
    • A young woman's story of genetic testing and risk-reducing mastectomy.
    • [No author given]
    • FORCE. XRAYS. 2019 Jun 6.

    Narrative: I Had a Preventive Mastectomy—Then Found Out I Already Had Breast Cancer. (Health)

    • [Recommendations for Preventive Care for Women with Rare Genetic Cause of Breast and Ovarian Cancer.]
    • Foretová L, Navrátilová M, Svoboda M, Vašíčková P, Sťahlová EH, Házová J, Kleiblová P, Kleibl Z, Macháčková E, Palácová M, Petráková K.
    • Klin Onkol. 2019 Summer;32(Supplementum2):6-13. doi: 10.14735/amko2019S6.
    • Hereditary Cancer Syndromes-A Primer on Diagnosis and Management: Part 1: Breast-Ovarian Cancer Syndromes.
    • Samadder NJ, Giridhar KV, Baffy N, Riegert-Johnson D, Couch FJ.
    • Mayo Clin Proc. 2019 Jun;94(6):1084-1098. doi: 10.1016/j.mayocp.2019.02.017.
    • [Epidemiology and diagnosis of breast cancer].
    • Budny A, Starosławska E, Budny B, Wójcik R, Hys M, Kozłowski P, Budny W, Brodzik A, Burdan F.
    • Pol Merkur Lekarski. 2019 May 27;46(275):195-204.
    • Review, [Article in Polish]
    • Recommendations for the implementation of BRCA testing in ovarian cancer patients and their relatives.
    • Gori S, Barberis M, Bella MA, Buttitta F, Capoluongo E, Carrera P, Colombo N, Cortesi L, Genuardi M, Gion M, Guarneri V, Incorvaia L, La Verde N, Lorusso D, Marchetti A, Marchetti P, Normanno N, Pasini B, Pensabene M, Pignata S, Radice P, Ricevuto E, Sapino A, Tagliaferri P, Tassone P, Trevisiol C, Truini M, Varesco L, Russo A; AIOM-SIGU-SIBIOC-SIAPEC-IAP Working Group.
    • Crit Rev Oncol Hematol. 2019 May 25;140:67-72. doi: 10.1016/j.critrevonc.2019.05.012. [Epub ahead of print]
    • Epithelial ovarian cancer: Evolution of management in the era of precision medicine.
    • Lheureux S, Braunstein M, Oza AM.
    • CA Cancer J Clin. 2019 May 17. doi: 10.3322/caac.21559. [Epub ahead of print]
    • Epithelial ovarian cancer risk: a review of the current genetic landscape.
    • Flaum N, Crosbie EJ, Edmondson RJ, Smith MJ, Evans DG.
    • Clin Genet. 2019 May 16. doi: 10.1111/cge.13566. [Epub ahead of print]
    • Review
    • Insights Into Breast Cancer in the East vs the West: A Review.
    • Yap YS, Lu YS, Tamura K, Lee JE, Ko EY, Park YH, Cao AY, Lin CH, Toi M, Wu J, Lee SC.
    • JAMA Oncol. 2019 May 16. doi: 10.1001/jamaoncol.2019.0620. [Epub ahead of print]
    • Review
    • BRCA Genes: The Role in Genome Stability, Cancer Stemness and Therapy Resistance.
    • Gorodetska I, Kozeretska I, Dubrovska A.
    • J Cancer. 2019 May 14;10(9):2109-2127. doi: 10.7150/jca.30410. eCollection 2019.
    • Cancer Genomics for Oncologists: Cancer Risk and Management of BRCA1 and BRCA2 Carriers.
    • George A.
    • Curr Genet Med Rep. 2019 May 9. doi: 10.1007/s40142-019-00167-6. [Epub ahead of print]
    • Review
    • Unraveling a difficult diagnosis: the tricks for early recognition of ovarian cancer.
    • Giampaolino P, Della Corte L, Foreste V, Vitale SG, Chiofalo B, Cianci S, Zullo F, Bifulco G.
    • Minerva Med. 2019 May 6. doi: 10.23736/S0026-4806.19.06086-5. [Epub ahead of print]
    • Review
    • Hereditary ovarian cancers: state of the art.
    • Toss A, Molinaro E, Sammarini M, Del Savio MC, Cortesi L, Facchinetti F, Grandi G.
    • Minerva Med. 2019 May 6. doi: 10.23736/S0026-4806.19.06091-9. [Epub ahead of print]
    • Review
    • Germline and Somatic Mutations in Prostate Cancer for the Clinician.
    • Cheng HH, Sokolova AO, Schaeffer EM, Small EJ, Higano CS.
    • J Natl Compr Canc Netw. 2019 May 1;17(5):515-521. doi: 10.6004/jnccn.2019.7307.
    • Whole genome sequencing of breast cancer.
    • Rossing M, Sørensen CS, Ejlertsen B, Nielsen FC.
    • APMIS. 2019 May;127(5):303-315. doi: 10.1111/apm.12920. Epub 2019 Jan 28.
    • Hereditary breast cancer; Genetic penetrance and current status with BRCA.
    • Mahdavi M, Nassiri M, Kooshyar MM, Vakili-Azghandi M, Avan A, Sandry R, Pillai S, Lam AK, Gopalan V.
    • J Cell Physiol. 2019 May;234(5):5741-5750. doi: 10.1002/jcp.27464. Epub 2018 Dec 14.
    • Review
    • Global Disparities in Breast Cancer Genetics Testing, Counselling and Management.
    • Yip CH, Evans DG, Agarwal G, Buccimazza I, Kwong A, Morant R, Prakash I, Song CY, Taib NA, Tausch C, Ung O, Meterissian S.
    • World J Surg. 2019 May;43(5):1264-1270. doi: 10.1007/s00268-018-04897-6.
    • BRCA Mutation Carriers: Breast and Ovarian Cancer Screening Guidelines and Imaging Considerations.
    • Elezaby M, Lees B, Maturen KE, Barroilhet L, Wisinski KB, Schrager S, Wilke LG, Sadowski E.
    • Radiology. 2019 Apr 30:181814. doi: 10.1148/radiol.2019181814. [Epub ahead of print]

    Letter, Comment:

    Breast Cancer Screening in BRCA Mutation Carriers: Necessity of a Relevant Update of Mammographic Modalities.

    • Reviewing the characteristics of BRCA and PALB2-related cancers in the precision medicine era.
    • Macedo GS, Alemar B, Ashton-Prolla P.
    • Genet Mol Biol. 2019 Apr 29. pii: S1415-47572019005015101. doi: 10.1590/1678-4685-GMB-2018-0104. [Epub ahead of print]
    • Scientific supremacy as an obstacle to establishing and sustaining interdisciplinary dialogue across knowledge paradigms in health medicine.
    • Gripsrud BH, Solbrække KN.
    • Med Health Care Philos. 2019 Apr 25. doi: 10.1007/s11019-019-09901-x. [Epub ahead of print]

    Commentary:

    Our genes, our selves: hereditary breast cancer and biological citizenship in Norway.

    Our genes, our selves: hereditary breast cancer and biological citizenship in Norway.

    • BRCA1-No Matter How You Splice It.
    • Li D, Harlan-Williams LM, Kumaraswamy E, Jensen RA.
    • Cancer Res. 2019 Apr 16. doi: 10.1158/0008-5472.CAN-18-3190. [Epub ahead of print]
    • Review
    • Epidemiological characteristics of and risk factors for breast cancer in the world.
    • Momenimovahed Z, Salehiniya H.
    • Breast Cancer (Dove Med Press). 2019 Apr 10;11:151-164. doi: 10.2147/BCTT.S176070. eCollection 2019.
    • Towards controlled terminology for reporting germline cancer susceptibility variants: an ENIGMA report.
    • Spurdle AB, Greville-Heygate S, Antoniou AC, Brown M, Burke L, de la Hoya M, Domchek S, Dörk T, Firth HV, Monteiro AN, Mensenkamp A, Parsons MT, Radice P, Robson M, Tischkowitz M, Tudini E, Turnbull C, Vreeswijk MP, Walker LC, Tavtigian S, Eccles DM.
    • J Med Genet. 2019 Apr 8. pii: jmedgenet-2018-105872. doi: 10.1136/jmedgenet-2018-105872. [Epub ahead of print]
    • Review, Guidelines
    • Identifying a BRCA2 c.5722_5723del mutation in a Han-Chinese family with breast cancer.
    • Guo Y, Wang P, Li X, Zhu S, Xu H, Li S, Deng H, Yuan L.
    • Biosci Rep. 2019 Apr 2. pii: BSR20182471. doi: 10.1042/BSR20182471. [Epub ahead of print]
    • Boosting care and knowledge about hereditary cancer: European Reference Network on Genetic Tumour Risk Syndromes.
    • Vos JR, Giepmans L, Röhl C, Geverink N, Hoogerbrugge N; ERN GENTURIS.
    • Fam Cancer. 2019 Apr;18(2):281-284. doi: 10.1007/s10689-018-0110-6.
    • Current Approaches to Cancer Genetic Counseling Services for Spanish-Speaking Patients.
    • Augusto B, Kasting ML, Couch FJ, Lindor NM, Vadaparampil ST.
    • J Immigr Minor Health. 2019 Apr;21(2):434-437. doi: 10.1007/s10903-018-0772-z.
    • Ovarian Cancer: An Integrated Review.
    • Stewart C, Ralyea C, Lockwood S.
    • Semin Oncol Nurs. 2019 Apr;35(2):151-156. doi: 10.1016/j.soncn.2019.02.001. Epub 2019 Mar 11.
    • Review
    • The BRCA Tumor Suppressor Network in Chromosome Damage Repair by Homologous Recombination.
    • Zhao W, Wiese C, Kwon Y, Hromas R, Sung P.
    • Annu Rev Biochem. 2019 Mar 27. doi: 10.1146/annurev-biochem-013118-111058. [Epub ahead of print]
    • Review
    • Breast surgeons recommend genetic testing for all breast cancer patients.
    • [No author given]
    • FORCE. XRAYS. 2019 Mar 25.

    Guideline: Consensus Guideline on Genetic Testing for Hereditary Breast Cancer. (PDF) (American Society of Breast Surgeons.)

    • Epithelial ovarian cancer.
    • Lheureux S, Gourley C, Vergote I, Oza AM.
    • Lancet. 2019 Mar 23;393(10177):1240-1253. doi: 10.1016/S0140-6736(18)32552-2.
    • Review
    • Genetic Testing to Guide Risk-Stratified Screens for Breast Cancer.
    • Willoughby A, Andreassen PR, Toland AE.
    • J Pers Med. 2019 Mar 1;9(1). pii: E15. doi: 10.3390/jpm9010015.
    • Hereditary cancer syndromes, their testing and prevention.
    • Foretová L.
    • Cas Lek Cesk. 2019 Spring;158(1):15-21.
    • Review
    • The Fanconi Anemia Pathway in Cancer.
    • Niraj J, Färkkilä A, D'Andrea AD.
    • Annu Rev Cancer Biol. 2019 Mar;3:457-478. doi: 10.1146/annurev-cancerbio-030617-050422. Epub 2018 Dec 3.
    • BRCA Exchange Launches.
    • [No authors listed]
    • Cancer Discov. 2019 Mar;9(3):311-312. doi: 10.1158/2159-8290.CD-NB2019-008. Epub 2019 Jan 24.
    • News
    • Author response to "a response to 'personalised medicine and population health: breast and ovarian cancer'".
    • Narod SA.
    • Hum Genet. 2019 Mar;138(3):291-292. doi: 10.1007/s00439-019-01981-2. Epub 2019 Feb 21.
    • Letter, Reply

    Letter, Commentary:

    A response to "Personalised medicine and population health: breast and ovarian cancer".

    Review:

    Personalised medicine and population health: breast and ovarian cancer.

    • Breast Cancer Screening: Why Can't Everyone Agree?
    • Jordan V, Khan M, Prill D.
    • Prim Care. 2019 Mar;46(1):97-115. doi: 10.1016/j.pop.2018.10.010. Epub 2018 Dec 22.
    • Review
    • Leveraging Implementation Science to Address Health Disparities in Genomic Medicine: Examples from the Field.
    • Roberts MC, Mensah GA, Khoury MJ.
    • Ethn Dis. 2019 Feb 21;29(Suppl 1):187-192. doi: 10.18865/ed.29.S1.187. eCollection 2019.
    • Women's cancers: how the discovery of BRCA genes is driving current concepts of cancer biology and therapeutics.
    • Murthy P, Muggia F.
    • Ecancermedicalscience. 2019 Feb 14;13:904. doi: 10.3332/ecancer.2019.904. eCollection 2019.
    • Consensus Guideline on Genetic Testing for Hereditary Breast Cancer.
    • Manahan ER, Sebastian M, Hughes KS, Boughey JC, Kuerer HM, Euhus DM, Robson ME, Boolbol SK, Arun BK, Taylor WA.
    • American Society of Breast Surgeons. 2019 Feb 10.

    Press: ASBrS Calls for Genetic Testing for All Breast Cancer Patients. (Medscape Oncology)

    News: Breast surgeons recommend genetic testing for all breast cancer patients. (FORCE. XRAYS.)

    • The cost of cancer care and impact of financial hardship on treatment.
    • [No author given]
    • FORCE. XRAYS. 2019 Feb 8.

    Original research:

    BRCA1 and BRCA2 Testing in Medically Underserved Medicare Beneficiaries With Breast or Ovarian Cancer.

    News: Labs, Advocacy Groups Push Back on Medicare Policy Shift on NGS Testing for Hereditary Cancer Risk. (GenomeWeb)

    News: Pricey Precision Medicine Often Financially Toxic For Cancer Patients. (Kaiser Health News)

    • Genetic Service Delivery Models: Exploring Approaches to Care for Families With Hereditary Cancer Risk.
    • Pierle JM, Mahon SM.
    • Clin J Oncol Nurs. 2019 Feb 1;23(1):60-67. doi: 10.1188/19.CJON.60-67.
    • Identifying breast cancer susceptibility genes - a review of the genetic background in familial breast cancer.
    • Wendt C, Margolin S.
    • Acta Oncol. 2019 Feb;58(2):135-146. doi: 10.1080/0284186X.2018.1529428. Epub 2019 Jan 3.
    • [Hereditary predisposition to breast cancer (1): genetics].
    • Cohen-Haguenauer O.
    • Med Sci (Paris). 2019 Feb;35(2):138-151. doi: 10.1051/medsci/2019003. Epub 2019 Feb 18.
    • Guidelines-Based Cancer Risk Assessment.
    • Forman A, Schwartz S.
    • Semin Oncol Nurs. 2019 Feb;35(1):34-46. doi: 10.1016/j.soncn.2018.12.010. Epub 2019 Jan 22.
    • Hereditary Breast and Hereditary Ovarian Cancer: Implications for the Oncology Nurse.
    • Beamer LC.
    • Semin Oncol Nurs. 2019 Feb;35(1):47-57. doi: 10.1016/j.soncn.2018.12.001. Epub 2019 Jan 30.
    • Shared heritability and functional enrichment across six solid cancers.
    • Jiang X, Finucane HK, Schumacher FR, Schmit SL, Tyrer JP, Han Y, Michailidou K, Lesseur C, Kuchenbaecker KB, Dennis J, Conti DV, Casey G, Gaudet MM, Huyghe JR, Albanes D, Aldrich MC, Andrew AS, Andrulis IL, Anton-Culver H, Antoniou AC, Antonenkova NN, Arnold SM, Aronson KJ, Arun BK, Bandera EV, Barkardottir RB, Barnes DR, Batra J, Beckmann MW, Benitez J, Benlloch S, Berchuck A, Berndt SI, Bickeböller H, Bien SA, Blomqvist C, Boccia S, Bogdanova NV, Bojesen SE, Bolla MK, Brauch H, Brenner H, Brenton JD, Brook MN, Brunet J, Brunnström H, Buchanan DD, Burwinkel B, Butzow R, Cadoni G, Caldés T, Caligo MA, Campbell I, Campbell PT, Cancel-Tassin G, Cannon-Albright L, Campa D, Caporaso N, Carvalho AL, Chan AT, Chang-Claude J, Chanock SJ, Chen C, Christiani DC, Claes KBM, Claessens F, Clements J, Collée JM, Correa MC, Couch FJ, Cox A, Cunningham JM, Cybulski C, Czene K, Daly MB, deFazio A, Devilee P, Diez O, Gago-Dominguez M, Donovan JL, Dörk T, Duell EJ, Dunning AM, Dwek M, Eccles DM, Edlund CK, Edwards DRV, Ellberg C, Evans DG, Fasching PA, Ferris RL, Liloglou T, Figueiredo JC, Fletcher O, Fortner RT, Fostira F, Franceschi S, Friedman E, Gallinger SJ, Ganz PA, Garber J, García-Sáenz JA, Gayther SA, Giles GG, Godwin AK, Goldberg MS, Goldgar DE, Goode EL, Goodman MT, Goodman G, Grankvist K, Greene MH, Gronberg H, Gronwald J, Guénel P, Håkansson N, Hall P, Hamann U, Hamdy FC, Hamilton RJ, Hampe J, Haugen A, Heitz F, Herrero R, Hillemanns P, Hoffmeister M, Høgdall E, Hong YC, Hopper JL, Houlston R, Hulick PJ, Hunter DJ, Huntsman DG, Idos G, Imyanitov EN, Ingles SA, Isaacs C, Jakubowska A, James P, Jenkins MA, Johansson M, Johansson M, John EM, Joshi AD, Kaneva R, Karlan BY, Kelemen LE, Kühl T, Khaw KT, Khusnutdinova E, Kibel AS, Kiemeney LA, Kim J, Kjaer SK, Knight JA, Kogevinas M, Kote-Jarai Z, Koutros S, Kristensen VN, Kupryjanczyk J, Lacko M, Lam S, Lambrechts D, Landi MT, Lazarus P, Le ND, Lee E, Lejbkowicz F, Lenz HJ, Leslie G, Lessel D, Lester J, Levine DA, Li L, Li CI, Lindblom A, Lindor NM, Liu G, Loupakis F, Lubiński J, Maehle L, Maier C, Mannermaa A, Marchand LL, Margolin S, May T, McGuffog L, Meindl A, Middha P, Miller A, Milne RL, MacInnis RJ, Modugno F, Montagna M, Moreno V, Moysich KB, Mucci L, Muir K, Mulligan AM, Nathanson KL, Neal DE, Ness AR, Neuhausen SL, Nevanlinna H, Newcomb PA, Newcomb LF, Nielsen FC, Nikitina-Zake L, Nordestgaard BG, Nussbaum RL, Offit K, Olah E, Olama AAA, Olopade OI, Olshan AF, Olsson H, Osorio A, Pandha H, Park JY, Pashayan N, Parsons MT, Pejovic T, Penney KL, Peters WHM, Phelan CM, Phipps AI, Plaseska-Karanfilska D, Pring M, Prokofyeva D, Radice P, Stefansson K, Ramus SJ, Raskin L, Rennert G, Rennert HS, van Rensburg EJ, Riggan MJ, Risch HA, Risch A, Roobol MJ, Rosenstein BS, Rossing MA, De Ruyck K, Saloustros E, Sandler DP, Sawyer EJ, Schabath MB, Schleutker J, Schmidt MK, Setiawan VW, Shen H, Siegel EM, Sieh W, Singer CF, Slattery ML, Sorensen KD, Southey MC, Spurdle AB, Stanford JL, Stevens VL, Stintzing S, Stone J, Sundfeldt K, Sutphen R, Swerdlow AJ, Tajara EH, Tangen CM, Tardon A, Taylor JA, Teare MD, Teixeira MR, Terry MB, Terry KL, Thibodeau SN, Thomassen M, Bjørge L, Tischkowitz M, Toland AE, Torres D, Townsend PA, Travis RC, Tung N, Tworoger SS, Ulrich CM, Usmani N, Vachon CM, Van Nieuwenhuysen E, Vega A, Aguado-Barrera ME, Wang Q, Webb PM, Weinberg CR, Weinstein S, Weissler MC, Weitzel JN, West CML, White E, Whittemore AS, Wichmann HE, Wiklund F, Winqvist R, Wolk A, Woll P, Woods M, Wu AH, Wu X, Yannoukakos D, Zheng W, Zienolddiny S, Ziogas A, Zorn KK, Lane JM, Saxena R, Thomas D, Hung RJ, Diergaarde B, McKay J, Peters U, Hsu L, García-Closas M, Eeles RA, Chenevix-Trench G, Brennan PJ, Haiman CA, Simard J, Easton DF, Gruber SB, Pharoah PDP, Price AL, Pasaniuc B, Amos CI, Kraft P, Lindström S.
    • Nat Commun. 2019 Jan 25;10(1):431. doi: 10.1038/s41467-018-08054-4.
    • Triple-negative breast cancer: the reality in Chile and in Latin America.
    • Caglevic C, Anabalón J, Soza C, Milla E, Gaete F, Carrasco AM, Panay S, Gallardo C, Mahave M.
    • Ecancermedicalscience. 2019 Jan 22;13:893. doi: 10.3332/ecancer.2019.893. eCollection 2019.
    • BRCA1 and Breast Cancer: a Review of the Underlying Mechanisms Resulting in the Tissue-Specific Tumorigenesis in Mutation Carriers.
    • Semmler L, Reiter-Brennan C, Klein A.
    • J Breast Cancer. 2019 Jan 22;22(1):1-14. doi: 10.4048/jbc.2019.22.e6. eCollection 2019 Mar.
    • Germline Genetic Testing for Breast Cancer Risk: The Past, Present, and Future.
    • Yadav S, Couch FJ.
    • Am Soc Clin Oncol Educ Book. 2019 Jan;(39):61-74. doi: 10.1200/EDBK_238987.
    • Molecular Testing in Breast Cancer.
    • Litton JK, Burstein HJ, Turner NC.
    • Am Soc Clin Oncol Educ Book. 2019 Jan;(39):e1-e7. doi: 10.1200/EDBK_237715.
    • BRCA mutations: is everything said?
    • López-Urrutia E, Salazar-Rojas V, Brito-Elías L, Coca-González M, Silva-García J, Sánchez-Marín D, Campos-Parra AD, Pérez-Plasencia C.
    • Breast Cancer Res Treat. 2019 Jan;173(1):49-54. doi: 10.1007/s10549-018-4986-5. Epub 2018 Oct 6.
    • Review
    • Challenges in the identification of inherited risk of ovarian cancer: where should we go from here?
    • Norquist BM.
    • Gynecol Oncol. 2019 Jan;152(1):3-6. doi: 10.1016/j.ygyno.2018.12.003. Epub 2018 Dec 8.
    • Epidemiology of Breast Cancer in Women.
    • Coughlin SS.
    • Adv Exp Med Biol. 2019;1152:9-29. doi: 10.1007/978-3-030-20301-6_2.
    • Review
    • Health and Racial Disparity in Breast Cancer.
    • Yedjou CG, Sims JN, Miele L, Noubissi F, Lowe L, Fonseca DD, Alo RA, Payton M, Tchounwou PB.
    • Adv Exp Med Biol. 2019;1152:31-49. doi: 10.1007/978-3-030-20301-6_3.
    • Review
    • Bilateral prophylactic mastectomy in BRCA mutation carriers: what surgeons need to know.
    • Franceschini G, Di Leone A, Terribile D, Sanchez MA, Masetti R.
    • Ann Ital Chir. 2019;90:1-2.
    • Review
    • A new look at molecular biology of breast cancer.
    • Ma C, Nepal M, Kim JH, Fan P, Fei P.
    • Cancer Biol Ther. 2019;20(1):1-5. doi: 10.1080/15384047.2018.1507259. Epub 2018 Sep 6.
    • BRCA Mutations and Breast Cancer Prevention.
    • Kotsopoulos J.
    • Cancers (Basel). 2018 Dec 19;10(12). pii: E524. doi: 10.3390/cancers10120524.
    • BRCA1-Dependent Transcriptional Regulation: Implication in Tissue-Specific Tumor Suppression.
    • Zhang X, Li R.
    • Cancers (Basel). 2018 Dec 14;10(12). pii: E513. doi: 10.3390/cancers10120513.
    • Gynecological-endocrinological aspects in women carriers of BRCA1/2 gene mutations.
    • Doren A, Vecchiola A, Aguirre B, Villaseca P.
    • Climacteric. 2018 Dec;21(6):529-535. doi: 10.1080/13697137.2018.1514006. Epub 2018 Oct 8.
    • Review
    • [III. Hereditary Breast and/or Ovarian Cancer Syndrome].
    • Sugitani I.
    • Gan To Kagaku Ryoho. 2018 Dec;45(12):1720-1724.
    • Review, [Article in Japanese]
    • Breast cancer in adolescents and young adults.
    • Johnson RH, Anders CK, Litton JK, Ruddy KJ, Bleyer A.
    • Pediatr Blood Cancer. 2018 Dec;65(12):e27397. doi: 10.1002/pbc.27397. Epub 2018 Aug 28.
    • Review
    • Big Data Sharing: A Crucial Democratic Issue for Genomic Medicine.
    • Derbez B.
    • Front Public Health. 2018 Nov 28;6:334. doi: 10.3389/fpubh.2018.00334. eCollection 2018.
    • Cancer genetics program: Follow-up on clinical genetics and genomic medicine in Qatar.
    • Al-Bader SB, Alsulaiman R, Bugrein H, Ben Omran T, Abbaszadeh F, Bakheet N, Apsa Kusasi S, Abdou N, Solomon BD, Ghazouani H.
    • Mol Genet Genomic Med. 2018 Nov;6(6):865-872. doi: 10.1002/mgg3.534. Epub 2018 Dec 16.
    • Risk-Reducing Options for Women with a Hereditary Breast Cancer Predisposition.
    • Jatoi I.
    • Eur J Breast Health. 2018 Oct 1;14(4):189-193. doi: 10.5152/ejbh.2018.4324. eCollection 2018 Oct.

    Letter, Review:

    What The Surgeons Should Know About The Bilateral Prophylactic Mastectomy in BRCA Mutation Carriers.

    • New Breast Cancer Screening Guidelines Build on Progress.
    • Larsen Haidle J.
    • NSGC blog, 2018 Oct 1.

    Guidelines: NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) — Genetic/Familial High-Risk Assessment: Breast and Ovarian (PDF) (NCCN.org)

    • Germline and somatic genetic testing in ovarian cancer patients.
    • Chandrasekaran D, Manchanda R.
    • BJOG. 2018 Oct;125(11):1460. doi: 10.1111/1471-0528.15225. Epub 2018 May 10.
    • Commentary
    • Personalised medicine and population health: breast and ovarian cancer.
    • Narod SA.
    • Hum Genet. 2018 Oct;137(10):769-778. doi: 10.1007/s00439-018-1944-6. Epub 2018 Oct 17.
    • Review

    Letter, Commentary:

    A response to "Personalised medicine and population health: breast and ovarian cancer".

    Letter, Reply:

    Author response to “a response to ‘personalised medicine and population health: breast and ovarian cancer’”.

    • Changing landscape of hereditary breast and ovarian cancer germline genetic testing in Australia.
    • Petelin L, James PA, Trainer AH.
    • Intern Med J. 2018 Oct;48(10):1269-1272. doi: 10.1111/imj.14058.
    • Commentary, Review
    • My Father’s Fight Against the Breast-Cancer Gene.
    • Munster P.
    • The Wall Street Journal. The Saturday Essay. 2018 Sep 28.

    Blog post: Pamela Munster's story: Cancer in the family (FORCE. XRAYS.)

    • Twisting Fate. My Journey with BRCA—from Breast Cancer Doctor to Patient and Back
    • Pamela Munster
    • The Experiment (publisher). 2018 Sep 25. ISBN 978-1-61519-478-0. 272 pages. Hardcover, Ebook.
    • Book

    Essay: My Father’s Fight Against the Breast-Cancer Gene. (The Wall Street Journal.)

    • Cancer experience in families affects decision making.
    • [No author given]
    • FORCE. XRAYS. 2018 Sep 25.

    Press: How a Loved One’s Experience With Cancer Guides Breast Cancer Decisions. (U.S. News & World Report)

    • How are genetic test results being used by Australian life insurers?
    • Barlow-Stewart K, Liepins M, Doble A, Otlowski M.
    • Eur J Hum Genet. 2018 Sep;26(9):1248-1256. doi: 10.1038/s41431-018-0198-z. Epub 2018 Jun 11.
    • Sporadic and Hereditary Breast Cancer Genetics.
    • Zehr KR.
    • Radiol Technol. 2018 Sep;90(1):51M-64M.
    • Review
    • Breast Cancer Genetics and Indications for Prophylactic Mastectomy.
    • Krontiras H, Farmer M, Whatley J.
    • Surg Clin North Am. 2018 Aug;98(4):677-685. doi: 10.1016/j.suc.2018.03.004. Epub 2018 May 30.
    • Review
    • NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) — Genetic/Familial High-Risk Assessment: Breast and Ovarian
    • Daly MB, Pilarski R, Berry M, Buys SS, Friedman S, Garber JE, Hutton ML, Kauff ND, Khan S, Klein C, Kohlmann W, Kurian A, Laronga C, Litton JK, Madlensky L, Mac JS, Merajver SD, Offit K, Pal T, Peterson HJ, Reiser G, Shannon KM, Thaker P, Visvanathan K, Weitzel JN, Wick MJ, Wisinski KB, Darlow S.
    • NCCN.org. 2018 Jul 11. Version 1.2019.
    • BRCA genes: BRCA 1 and BRCA 2.
    • Varol U, Kucukzeybek Y, Alacacioglu A, Somali I, Altun Z, Aktas S, Oktay Tarhan M.
    • J BUON. 2018 Jul-Aug;23(4):862-866.
    • Clinical Cancer Genetics in a Lower-Middle Income Country: Considerations for Policymaking.
    • Ginsburg O, Narod SA.
    • J Glob Oncol. 2018 Jul;(4):1-3. doi: 10.1200/JGO.18.00081.

    Knowledge of Genetic Counseling Among Patients With Breast Cancer and Their Relatives at a Nigerian Teaching Hospital.

    • First international TNBC conference meeting report.
    • Rida P, Ogden A, Ellis IO, Varga Z, Wolff AC, Traina TA, Hatzis C, Palmer JR, Ambrosone CB, Lehmann BD, Nanda R, Montgomery Rice V, Brawley OW, Torres MA, Rakha E, Aneja R.
    • Breast Cancer Res Treat. 2018 Jun;169(3):407-412. doi: 10.1007/s10549-018-4692-3. Epub 2018 Feb 8.
    • Review, Conference report
    • Our genes, our selves: hereditary breast cancer and biological citizenship in Norway.
    • Møller P, Hovig E.
    • Med Health Care Philos. 2018 Jun;21(2):239-242. doi: 10.1007/s11019-017-9803-0.

    Our genes, our selves: hereditary breast cancer and biological citizenship in Norway.

    Commentary, Reply:

    Scientific supremacy as an obstacle to establishing and sustaining interdisciplinary dialogue across knowledge paradigms in health medicine.

    • BRCA Mutations in the Young, High-Risk Female Population: Genetic Testing, Management of Prophylactic Therapies, and Implications for Plastic Surgeons.
    • Salibian AA, Frey JD, Choi M, Karp NS.
    • Plast Reconstr Surg. 2018 Jun;141(6):1341-1350. doi: 10.1097/PRS.0000000000004363.
    • Breast cancer development and progression: Risk factors, cancer stem cells, signaling pathways, genomics, and molecular pathogenesis.
    • Feng Y, Spezia M, Huang S, Yuan C, Zeng Z, Zhang L, Ji X, Liu W, Huang B, Luo W, Liu B, Lei Y, Du S, Vuppalapati A, Luu HH, Haydon RC, He TC, Ren G.
    • Genes Dis. 2018 May 12;5(2):77-106. doi: 10.1016/j.gendis.2018.05.001. eCollection 2018 Jun.
    • 4th International Consensus Conference on Advanced Breast Cancer (ABC4), Lisbon, November 4, 2017 : ABC4 Consensus: Assessment by a Panel of German Experts.
    • Untch M, Würstlein R, Marschner N, Lüftner D, Augustin D, Briest S, Ettl J, Haidinger R, Müller L, Müller V, Ruckhäberle E, Harbeck N, Thomssen C.
    • Geburtshilfe Frauenheilkd. 2018 May;78(5):469-480. doi: 10.1055/a-0594-2243. Epub 2018 Jun 4.
    • Risk, Prediction and Prevention of Hereditary Breast Cancer - Large-Scale Genomic Studies in Times of Big and Smart Data.
    • Wunderle M, Olmes G, Nabieva N, Häberle L, Jud SM, Hein A, Rauh C, Hack CC, Erber R, Ekici AB, Hoyer J, Vasileiou G, Kraus C, Reis A, Hartmann A, Schulz-Wendtland R, Lux MP, Beckmann MW, Fasching PA.
    • Geburtshilfe Frauenheilkd. 2018 May;78(5):481-492. doi: 10.1055/a-0603-4350. Epub 2018 Jun 4.
    • Not quite healthy, not quite sick, women at risk of hereditary cancer can 'fall through the medical cracks'.
    • Karlamangla S.
    • Los Angeles Times, Health & Wellness, 2018 Apr 8.
    • PALB2 (partner and localizer of BRCA2).
    • Hanenberg H, Andreassen PR.
    • Atlas Genet Cytogenet Oncol Haematol. 2018 Apr;22(12):484-490. doi: 10.4267/2042/69016.
    • BRCA1 mutation spectrum, functions, and therapeutic strategies: The story so far.
    • Sharma B, Preet Kaur R, Raut S, Munshi A.
    • Curr Probl Cancer. 2018 Mar - Apr;42(2):189-207. doi: 10.1016/j.currproblcancer.2018.01.001. Epub 2018 Jan 8.
    • Review
    • Hereditary Breast and Ovarian Cancer Syndrome: Moving Beyond BRCA1 and BRCA2.
    • Hoang LN, Gilks BC.
    • Adv Anat Pathol. 2018 Mar;25(2):85-95. doi: 10.1097/PAP.0000000000000177.
    • Review
    • Homology-Directed Repair and the Role of BRCA1, BRCA2, and Related Proteins in Genome Integrity and Cancer.
    • Chen CC, Feng W, Lim PX, Kass EM, Jasin M.
    • Annu Rev Cancer Biol. 2018 Mar;2:313-336. doi: 10.1146/annurev-cancerbio-030617-050502. Epub 2017 Dec 1.
    • Recommendations for biomarker testing in epithelial ovarian cancer: a National Consensus Statement by the Spanish Society of Pathology and the Spanish Society of Medical Oncology.
    • Oaknin A, Guarch R, Barretina P, Hardisson D, González A, Matías-Guiu X, Pérez-Fidalgo A, Vieites B, Romero I, Palacios J.
    • Clin Transl Oncol. 2018 Mar;20(3):274-285. doi: 10.1007/s12094-017-1719-x. Epub 2017 Aug 16.
    • Update Breast Cancer 2018 (Part 2) - Advanced Breast Cancer, Quality of Life and Prevention.
    • Schneeweiss A, Lux MP, Janni W, Hartkopf AD, Nabieva N, Taran FA, Overkamp F, Kolberg HC, Hadji P, Tesch H, Wöckel A, Ettl J, Lüftner D, Wallwiener M, Müller V, Beckmann MW, Belleville E, Wallwiener D, Brucker SY, Schütz F, Fasching PA, Fehm TN.
    • Geburtshilfe Frauenheilkd. 2018 Mar;78(3):246-259. doi: 10.1055/s-0044-101614. Epub 2018 Mar 21.
    • Hereditary Cancers in Gynecology: What Physicians Should Know About Genetic Testing, Screening, and Risk Reduction.
    • Ring KL, Modesitt SC.
    • Obstet Gynecol Clin North Am. 2018 Mar;45(1):155-173. doi: 10.1016/j.ogc.2017.10.011.
    • Review
    • Hereditary breast cancer: molecular biology and management update.
    • Yamashita H.
    • Int J Clin Oncol. 2018 Feb;23(1):35. doi: 10.1007/s10147-017-1183-1. Epub 2017 Aug 24.
    • BRCA1 gene: function and deficiency.
    • Takaoka M, Miki Y.
    • Int J Clin Oncol. 2018 Feb;23(1):36-44. doi: 10.1007/s10147-017-1182-2. Epub 2017 Sep 7.
    • Review
    • Gynaecological neoplasms in common familial syndromes (Lynch and HBOC).
    • Bartosch C, Clarke B, Bosse T.
    • Pathology. 2018 Feb;50(2):222-237. doi: 10.1016/j.pathol.2017.10.010. Epub 2017 Dec 26.
    • Review
    • A comprehensive analysis of BRCA2 gene: focus on mechanistic aspects of its functions, spectrum of deleterious mutations, and therapeutic strategies targeting BRCA2-deficient tumors.
    • Shailani A, Kaur RP, Munshi A.
    • Med Oncol. 2018 Jan 31;35(3):18. doi: 10.1007/s12032-018-1085-8.
    • Review
    • Your Genes: One Size Doesn't Fit All.
    • Freivogel ME, Cohen SA.
    • J Natl Compr Canc Netw. 2018 Jan 1;16(1):2-3. doi: 10.6004/jnccn.2017.7055.
    • Commentary

    Commentary:

    Your Genes: Getting the Best Fit.

    • Considerations in Testing for Inherited Breast Cancer Predisposition in the Era of Personalized Medicine.
    • Powers B, Pal T, Laronga C.
    • Surg Oncol Clin N Am. 2018 Jan;27(1):1-22. doi: 10.1016/j.soc.2017.08.003.
    • Review
    • Breast Cancer Disparities: How Can We Leverage Genomics to Improve Outcomes?
    • Davis MB, Newman LA.
    • Surg Oncol Clin N Am. 2018 Jan;27(1):217-234. doi: 10.1016/j.soc.2017.07.009.
    • Review
    • The Rise and Fall and Rise of Linkage Analysis as a Technique for Finding and Characterizing Inherited Influences on Disease Expression.
    • Lipner EM, Greenberg DA.
    • Methods Mol Biol. 2018;1706:381-397. doi: 10.1007/978-1-4939-7471-9_21.
    • Review
    • The Preventive Intervention of Hereditary Breast Cancer.
    • Cao A, Huang L, Shao Z.
    • Adv Exp Med Biol. 2017 [2017 Dec 28];1026:41-57. doi: 10.1007/978-981-10-6020-5_3.
    • Review
    • BRCA 1 and 2.
    • Casaubon JT, Regan JP.
    • StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2017-. 2017 Dec 8.
    • Identification and management of familial breast cancer in Austria.
    • Singer CF, Tan YY, Rappaport C.
    • Horm Mol Biol Clin Investig. 2017 Nov 30;32(2). pii: /j/hmbci.2017.32.issue-2/hmbci-2017-0025/hmbci-2017-0025.xml. doi: 10.1515/hmbci-2017-0025.
    • Review
    • Genetics of Breast and Gynecologic Cancers (PDQ®): Health Professional Version.
    • PDQ Cancer Genetics Editorial Board.
    • PDQ Cancer Information Summaries [Internet]. Bethesda, MD: National Cancer Institute. Updated 2017 Nov 30. Accessed 2017 Dec 8.
    • Testing for BRCA1/2 Mutations.
    • Sefton P.
    • JAMA. 2017 Nov 28;318(20):2054. doi: 10.1001/jama.2017.17280.
    • International Szent-Györgyi Prize for Progress in Cancer Research: basic and translational research recognition : Mary-Claire King received the 2016 Prize for her pioneering research that demonstrated the first evidence of genetic predisposition to breast cancer.
    • Hartmann H, Zhao J, Ba S.
    • Chin J Cancer. 2017 Nov 21;36(1):92. doi: 10.1186/s40880-017-0258-8.
    • Non-BRCA1/2 Breast Cancer Susceptibility Genes: A New Frontier with Clinical Consequences for Plastic Surgeons.
    • Frey JD, Salibian AA, Schnabel FR, Choi M, Karp NS.
    • Plast Reconstr Surg Glob Open. 2017 Nov 20;5(11):e1564. doi: 10.1097/GOX.0000000000001564. eCollection 2017 Nov.
    • BRCA mutations in the manifestation and treatment of ovarian cancer.
    • Pan Z, Xie X.
    • Oncotarget. 2017 May 30;8(57):97657-97670. doi: 10.18632/oncotarget.18280. eCollection 2017 Nov 14.
    • Current and future role of genetic screening in gynecologic malignancies.
    • Ring KL, Garcia C, Thomas MH, Modesitt SC.
    • Am J Obstet Gynecol. 2017 Nov;217(5):512-521. doi: 10.1016/j.ajog.2017.04.011. Epub 2017 Apr 12.
    • Missed therapeutic and prevention opportunities in women with BRCA-mutated epithelial ovarian cancer and their families due to low referral rates for genetic counseling and BRCA testing: A review of the literature.
    • Hoskins PJ, Gotlieb WH.
    • CA Cancer J Clin. 2017 Nov;67(6):493-506. doi: 10.3322/caac.21408. Epub 2017 Sep 7.
    • Ovarian Cancer Prevention, Screening, and Early Detection: Report From the 11th Biennial Ovarian Cancer Research Symposium.
    • Chien J, Poole EM.
    • Int J Gynecol Cancer. 2017 Nov;27(9S Suppl 5):S20-S22. doi: 10.1097/IGC.0000000000001118.
    • Conference report
    • Genetic Testing: Challenges and Changes in Testing for Hereditary Cancer Syndromes.
    • King E, Mahon SM.
    • Clin J Oncol Nurs. 2017 Oct 1;21(5):589-598. doi: 10.1188/17.CJON.589-598.
    • Germline Genetic Variants with Implications for Disease Risk and Therapeutic Outcomes.
    • Pasternak AL, Ward KM, Luzum JA, Ellingrod VL, Hertz DL.
    • Physiol Genomics. 2017 Oct 1;49(10):567-581. doi: 10.1152/physiolgenomics.00035.2017. Epub 2017 Sep 8.
    • Review
    • Integrating surgery and genetic testing for the modern surgeon.
    • Caso R, Beamer M, Lofthus AD, Sosin M.
    • Ann Transl Med. 2017 Oct;5(20):399. doi: 10.21037/atm.2017.06.50.
    • Prognostic impact of germline mutations in inherited cancer syndromes.
    • Corso G, Feroce I, Intra M, Veronesi P, Sacchini V, Bonanni B, Galimberti V.
    • Future Oncol. 2017 Oct;13(24):2125-2127. doi: 10.2217/fon-2017-0296. Epub 2017 Oct 6.
    • Editorial, Review
    • Impact of germline and somatic BRCA1/2 mutations: Tumor spectrum and detection platforms.
    • Wu H, Wu X, Liang Z.
    • Gene Ther. 2017 Oct;24(10):601-609. doi: 10.1038/gt.2017.73. Epub 2017 Aug 3.
    • Review
    • Breast cancer genetics in young women: What do we know?
    • Gómez-Flores-Ramos L, Álvarez-Gómez RM, Villarreal-Garza C, Wegman-Ostrosky T, Mohar A.
    • Mutat Res. 2017 Oct;774:33-45. doi: 10.1016/j.mrrev.2017.08.001. Epub 2017 Aug 25.
    • Review
    • The Evolution, Functions and Applications of the Breast Cancer Genes BRCA1 and BRCA2.
    • Pfeffer CM, Ho BN, Singh ATK.
    • Cancer Genomics Proteomics. 2017 Sep-Oct;14(5):293-298.
    • Your Genes: Getting the Best Fit.
    • Tempero M.
    • J Natl Compr Canc Netw. 2017 Sep;15(9):1083. doi: 10.6004/jnccn.2017.0152.

    Deleterious Germline Mutations in Patients With Apparently Sporadic Pancreatic Adenocarcinoma.

    Commentary: Your Genes: One Size Doesn't Fit All (Journal of the National Comprehensive Cancer Network)

    • Practice Bulletin No 182: Hereditary Breast and Ovarian Cancer Syndrome.
    • Committee on Practice Bulletins–Gynecology, Committee on Genetics, Society of Gynecologic Oncology.
    • Obstet Gynecol. 2017 Sep;130(3):e110-e126. doi: 10.1097/AOG.0000000000002296.
    • Guidelines

    Summary:

    Practice Bulletin No. 182 Summary: Hereditary Breast and Ovarian Cancer Syndrome.

    • Committee Opinion No. 716: The Role of the Obstetrician-Gynecologist in the Early Detection of Epithelial Ovarian Cancer in Women at Average Risk.
    • Committee on Gynecologic Practice, Society of Gynecologic Oncology.
    • Obstet Gynecol. 2017 Sep;130(3):e146-e149. doi: 10.1097/AOG.0000000000002299.

    Summary:

    Committee Opinion No. 716 Summary: The Role of the Obstetrician-Gynecologist in the Early Detection of Epithelial Ovarian Cancer in Women at Average Risk.

    • Breast Cancer Genetics for Plastic Surgeons.
    • McInerney NM, Narod S, Metcalfe K, Semple J, Brown MH.
    • Plast Reconstr Surg. 2017 Sep;140(3):455-460. doi: 10.1097/PRS.0000000000003577.
    • Review
    • [The progress and prospect of application of genetic testing technology-based gene detection technology in the diagnosis and treatment of hereditary cancer].
    • He JX, Jiang YF.
    • Zhonghua Yu Fang Yi Xue Za Zhi. 2017 Aug 6;51(8):772-776. doi: 10.3760/cma.j.issn.0253-9624.2017.08.022.
    • Review; Article in Chinese; Abstract in English, Chinese
    • Barriers and Facilitating Factors for Implementation of Genetic Services: A Public Health Perspective.
    • Cornel MC, van El CG.
    • Front Public Health. 2017 Aug 4;5:195. doi: 10.3389/fpubh.2017.00195. eCollection 2017.
    • BRCA mutation in ovarian cancer: testing, implications and treatment considerations.
    • Neff RT, Senter L, Salani R.
    • Ther Adv Med Oncol. 2017 Aug;9(8):519-531. doi: 10.1177/1758834017714993. Epub 2017 Jun 19.
    • Inherited mutations in DNA repair genes and cancer risk.
    • Romero-Laorden N, Castro E.
    • Curr Probl Cancer. 2017 Jul - Aug;41(4):251-264. doi: 10.1016/j.currproblcancer.2017.02.009. Epub 2017 Mar 22.
    • Review
    • BRCA-associated Cancers: Role of Imaging in Screening, Diagnosis, and Management.
    • Lee MV, Katabathina VS, Bowerson ML, Mityul MI, Shetty AS, Elsayes KM, Balachandran A, Bhosale PR, McCullough AE, Menias CO.
    • Radiographics. 2017 Jul-Aug;37(4):1005-1023. doi: 10.1148/rg.2017160144. Epub 2017 May 26.
    • Review
    • Genetics of gynaecological cancers.
    • Constantinou P, Tischkowitz M.
    • Best Pract Res Clin Obstet Gynaecol. 2017 Jul;42:114-124. doi: 10.1016/j.bpobgyn.2017.01.004. Epub 2017 Jan 24.
    • Review
    • European/U.S. Comparison and Contrasts in Ovarian Cancer Screening and Prevention in a High-Risk Population.
    • Mourits MJ, de Bock GH.
    • Am Soc Clin Oncol Educ Book. [Presented Sunday, June 4, 2017.] 2017;37:124-127. doi: 10.14694/EDBK_180330.
    • [Breast Cancer in Young Women - Correlation of Clinical Histomorphological, and Molecular-genetic Features of Breast Carcinoma in Women Younger than 35 Years of Age].
    • Metelková A, Skálová A, Fínek J.
    • Klin Onkol. 2017 Summer;30(3):202-209. doi: 10.14735/amko2017202.
    • Breast cancer and genomic testing.
    • Liedtke C, Kolberg HC.
    • Br J Surg. 2017 Jun;104(7):799-801. doi: 10.1002/bjs.10513. Epub 2017 Mar 16.
    • Highlights of the San Antonio Breast Cancer Symposium 2016.
    • Benson JR, Jatoi I.
    • Future Oncol. 2017 Jun;13(15):1291-1295. doi: 10.2217/fon-2017-0088. Epub 2017 Jun 26.
    • Therapeutic and Preventive Implications of Moonshot in Hereditary Cancer Syndromes.
    • Diab O, Chintalacheruvu LM, Lynch HT.
    • JAMA Oncol. 2017 May 1;3(5):592-593. doi: 10.1001/jamaoncol.2016.3046.
    • Commentary
    • Imaging of Hereditary Tumors of the Female Genital System.
    • Rothan SM, Menias CO, ElGuindy YM, Jensen CT, Shaaban A, Bhosale P, Lee MV, Katabathina VS, Elsayes KM.
    • J Comput Assist Tomogr. 2017 May/Jun;41(3):364-375. doi: 10.1097/RCT.0000000000000558.
    • Review
    • European/U.S. Comparison and Contrasts in Ovarian Cancer Screening and Prevention in a High-Risk Population.
    • Mourits MJ, de Bock GH.
    • Am Soc Clin Oncol Educ Book. 2017 May;(37):124-127. doi: 10.1200/EDBK_180330.
    • Hereditary Ovarian Cancer and Risk Reduction.
    • Andrews L, Mutch DG.
    • Best Pract Res Clin Obstet Gynaecol. 2017 May;41:31-48. doi: 10.1016/j.bpobgyn.2016.10.017. Epub 2017 Jan 17.
    • Review
    • [Hereditary breast and ovarian cancer].
    • Lax SF.
    • Pathologe. 2017 May;38(3):149-155. doi: 10.1007/s00292-017-0298-5.
    • Next Generation Sequencing and Multi-Gene Panel Testing: Implications for the Oncology Nurse.
    • Kelly PA.
    • Semin Oncol Nurs. 2017 May;33(2):208-218. doi: 10.1016/j.soncn.2017.02.007. Epub 2017 Apr 5.
    • Review
    • An alternative model for (breast) cancer predisposition.
    • Teugels E, De Brakeleer S.
    • NPJ Breast Cancer. 2017 Apr 17;3:13. doi: 10.1038/s41523-017-0017-7. eCollection 2017.
    • BRCA mutation genetic testing implications in the United States.
    • Bayraktar S, Arun B.
    • Breast. 2017 Feb;31:224-232. doi: 10.1016/j.breast.2016.11.021. Epub 2016 Dec 6.
    • Pathogenesis and heterogeneity of ovarian cancer.
    • Kroeger PT Jr, Drapkin R.
    • Curr Opin Obstet Gynecol. 2017 Feb;29(1):26-34. doi: 10.1097/GCO.0000000000000340.
    • [Molecular Diagnosis and Treatment of HBOC Syndrome].
    • Miki Y.
    • Gan To Kagaku Ryoho. 2017 Feb;44(2):102-106.
    • Review, [Article in Japanese]
    • [Clinical Management of HBOC in Our Hospital].
    • Nomura H, Takeshima N.
    • Gan To Kagaku Ryoho. 2017 Feb;44(2):116-120.
    • [Article in Japanese]
    • BRCA1 and BRCA2 mutations and treatment strategies for breast cancer.
    • Godet I, Gilkes DM.
    • Integr Cancer Sci Ther. 2017 Feb;4(1). doi: 10.15761/ICST.1000228. Epub 2017 Feb 27.
    • [Can new molecular profiles in epithelial ovarian cancer modify therapeutics?]
    • Lavoué V, Rousselin A, Delplanque S, Pinsard M, Henno S, Foucher F, Levêque J, de la Motte Rouge T.
    • J Gynecol Obstet Hum Reprod. 2017 Feb;46(2):107-112. doi: 10.1016/j.jogoh.2016.09.002. Epub 2017 Jan 30.
    • Review, [Article in French]
    • Understanding breast cancer - The long and winding road.
    • Lukong KE.
    • BBA Clin. 2017 Jan 27;7:64-77. doi: 10.1016/j.bbacli.2017.01.001. eCollection 2017.
    • Hereditary cancer syndromes in Latino populations: genetic characterization and surveillance guidelines.
    • Cruz-Correa M, Pérez-Mayoral J, Dutil J, Echenique M, Mosquera R, Rivera-Román K, Umpierre S, Rodriguez-Quilichini S, Gonzalez-Pons M, Olivera MI, Pardo S; Puerto Rico Clinical Cancer Genetics Consortia.
    • Hered Cancer Clin Pract. 2017 Jan 21;15:3. doi: 10.1186/s13053-017-0063-z. eCollection 2017.
    • "Angelina Jolie Effect”: What Should I Know About Hereditary Cancer and Testing?
    • Erica Ramos.
    • NSGC Blog. 2017 Jan 18.
    • Blog post
    • Breast cancer risk prediction using a polygenic risk score in the familial setting: a prospective study from the Breast Cancer Family Registry and kConFab.
    • Li H, Feng B, Miron A, Chen X, Beesley J, Bimeh E, Barrowdale D, John EM, Daly MB, Andrulis IL, Buys SS, Kraft P; kConFab investigators, Thorne H, Chenevix-Trench G, Southey MC, Antoniou AC, James PA, Terry MB, Phillips KA, Hopper JL, Mitchell G, Goldgar DE.
    • Genet Med. 2017 Jan;19(1):30-35. doi: 10.1038/gim.2016.43. Epub 2016 May 12.
    • Breast Cancer Epidemiology, Prevention, and Screening.
    • Winters S, Martin C, Murphy D, Shokar NK.
    • Prog Mol Biol Transl Sci. 2017;151:1-32. doi: 10.1016/bs.pmbts.2017.07.002. Epub 2017 Oct 10.
    • Review
    • BRCA1- and BRCA2-Associated Hereditary Breast and Ovarian Cancer.
    • Petrucelli N, Daly MB, Pal T.
    • GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. 1998 Sep 04 [updated 2016 Dec 15].
    • Breast Cancer: Genetics and Risk Assessment.
    • Tejada-Bergés T.
    • Clin Obstet Gynecol. 2016 Dec;59(4):673-687.
    • CDC Grand Rounds: Family History and Genomics as Tools for Cancer Prevention and Control.
    • Rodriguez JL, Thomas CC, Massetti GM, Duquette D, Avner L, Iskander J, Khoury MJ, Richardson LC.
    • MMWR Morb Mortal Wkly Rep. 2016 Nov 25;65(46):1291-1294. doi: 10.15585/mmwr.mm6546a3.
    • New Toolkit Can Help Debunk Myths About Genetic Testing for Gynecologic Cancer.
    • Casey A.
    • Cure. 2016 Oct 27.

    Review. Toolkit: 2016 Genetics Toolkit (Society of Gynecologic Oncology)

    • Be a “Know-It-All” About Your Breast Cancer Risk.
    • Mary Freivogel.
    • NSGC Blog. 2016 Oct 26.
    • Blog post
    • Genetic Tests That Make a Difference After a Breast Cancer Diagnosis.
    • Marisa C. Weiss
    • U.S. News and World Report. Health Care. Oct. 24, 2016.
    • Assessing, Counseling, and Treating Patients at High Risk for Breast Cancer.
    • Clifford E, Hughes KS, Roberts M, Pirzadeh-Miller S, McLaughlin SA.
    • Ann Surg Oncol. 2016 Oct;23(10):3128-32. doi: 10.1245/s10434-016-5399-5. Epub 2016 Jul 11.
    • Review
    • Identification and management of women with a family history of breast cancer: Practical guide for clinicians.
    • Heisey R, Carroll JC.
    • Can Fam Physician. 2016 Oct;62(10):799-803.
    • Updates on breast cancer genetics: Clinical implications of detecting syndromes of inherited increased susceptibility to breast cancer.
    • Cobain EF, Milliron KJ, Merajver SD.
    • Semin Oncol. 2016 Oct;43(5):528-535. doi: 10.1053/j.seminoncol.2016.10.001. Epub 2016 Oct 8.
    • Review
    • Genetic predisposition in gynecologic cancers.
    • Daniels MS, Lu KH.
    • Semin Oncol. 2016 Oct;43(5):543-547. doi: 10.1053/j.seminoncol.2016.08.005. Epub 2016 Sep 20.
    • Review
    • Strategies for clinical implementation of screening for hereditary cancer syndromes.
    • Heald B, Marquard J, Funchain P.
    • Semin Oncol. 2016 Oct;43(5):609-614. doi: 10.1053/j.seminoncol.2016.08.008. Epub 2016 Sep 21.
    • Review
    • Pandora’s DNA: Tracing the Breast Cancer Genes Through History, Science, and One Family Tree
    • Robertson C.
    • Book Review, Perspectives in Genetic Counseling, Volume 38, Number 3, p. 16. 2016 Qtr 3.
    • Translating genetics beyond bench and bedside: A comparative perspective on health care infrastructures for 'familial' breast cancer.
    • Aarden E.
    • Appl Transl Genom. 2016 Sep 29;11:48-54. doi: 10.1016/j.atg.2016.09.001. eCollection 2016.
    • Why I Won’t Get the Genetic Test for Breast Cancer.
    • Cynthia Graber.
    • Wired. Science. 2016 Sep 27.

    News: Genetic testing has become more affordable and available. Should you get it? (FORCE)

    • BRCA to the future: towards best testing practice in the era of personalised healthcare.
    • Capoluongo E.
    • Eur J Hum Genet. 2016 Sep;24 Suppl 1:S1-2. doi: 10.1038/ejhg.2016.92.
    • New challenges for BRCA testing: a view from the diagnostic laboratory.
    • Wallace AJ.
    • Eur J Hum Genet. 2016 Sep;24 Suppl 1:S10-8. doi: 10.1038/ejhg.2016.94.
    • Ovarian cancer.
    • Matulonis UA, Sood AK, Fallowfield L, Howitt BE, Sehouli J, Karlan BY.
    • Nat Rev Dis Primers. 2016 Aug 25;2:16061. doi: 10.1038/nrdp.2016.61.
    • Review
    • Women at high risk of breast cancer: Molecular characteristics, clinical presentation and management.
    • Kleibl Z, Kristensen VN.
    • Breast. 2016 Aug;28:136-44. doi: 10.1016/j.breast.2016.05.006. Epub 2016 Jun 16.
    • Review

    Comments on NSGC Discussion Forum Cancer SIG

    Subject: CHEK2 and adjuvant radiation therapy

    • Methods to identify BRCA testing in claims data.
    • Lynch J, Berse B.
    • Am J Obstet Gynecol. 2016 Jul;215(1):133-4. doi: 10.1016/j.ajog.2016.03.049. Epub 2016 Apr 12.

    Letter / Reply:

    Reply.

    • [Latest international guidelines for screening, prevention and treatment of familial breast cancer - implications for the relevant practice in Hungary].
    • Romics L, Kocsis J, Ormándi K, Molnár BÁ.
    • Orv Hetil. 2016 Jul;157(28):1117-25. doi: 10.1556/650.2016.30473.
    • Diagnosis and Management of Ovarian Cancer.
    • Doubeni CA, Doubeni AR, Myers AE.
    • Am Fam Physician. 2016 Jun 1;93(11):937-44.
    • Genetic testing for hereditary breast cancer in Asia-moving forward.
    • Kwong A.
    • Chin Clin Oncol. 2016 Jun;5(3):47. doi: 10.21037/cco.2016.05.11.
    • [BRCA mutations: from Angelina Jolie to specific therapies].
    • Lopez VA, Stravodimou A, Unger S, Perey L, Zaman K.
    • Rev Med Suisse. 2016 May 18;12(519):973-4, 976-7.
    • Review, [Article in French]
    • Here’s what men need to know about the Angelina Jolie ‘breast-cancer gene’.
    • Laurie McGinley.
    • Washington Post. To Your Health. 2016 May 17.
    • Defective ‘breast cancer’ genes aren’t just dangerous for women. They’re also linked to aggressive cancer in men.
    • Laurie McGinley.
    • Washington Post. To Your Health. 2016 May 15.
    • Angelina's Impact: Genetic Counselors Share.
    • [No author given]
    • My Gene Counsel. 2016 May 14.
    • Angelina's Impact: Advocates Share.
    • [No author given]
    • My Gene Counsel. 2016 May 14.
    • Oncogenetics service and the Brazilian public health system: the experience of a reference Cancer Hospital.
    • Palmero EI, Galvão HC, Fernandes GC, Paula AE, Oliveira JC, Souza CP, Andrade CE, Romagnolo LG, Volc S, C Neto M, Sabato C, Grasel R, Mauad E, Reis RM, Michelli RA.
    • Genet Mol Biol. 2016 May 13;39(2):168-177. doi: 10.1590/1678-4685-GMB-2014-0364.
    • Ovarian Cancer and BRCA1/2 Testing: Opportunities to Improve Clinical Care and Disease Prevention.
    • Karakasis K, Burnier JV, Bowering V, Oza AM, Lheureux S.
    • Front Oncol. 2016 May 11;6:119. doi: 10.3389/fonc.2016.00119. eCollection 2016.
    • Evolving Approaches in Research and Care for Ovarian Cancers: A Report From the National Academies of Sciences, Engineering, and Medicine.
    • Levine DA, Karlan BY, Strauss JF 3rd.
    • JAMA. 2016 May 10;315(18):1943-4. doi: 10.1001/jama.2016.2640.
    • Women's Health Issues for BRCA Mutation Carriers.
    • Sabatini ME, Ellisen LW.
    • Am Soc Clin Oncol Educ Book. 2016 May;(36):14-17. doi: 10.1200/EDBK_100001.
    • More People Seek Genetic Testing, But There Aren't Enough Counselors.
    • Todd Bookman.
    • NPR. Morning Edition. 2016 Apr 18.
    • NCCN Adds New Gene Mutations to Consider in Women's Cancers.
    • Fran Lowry.
    • Medscape Medical News. Oncology. National Comprehensive Cancer Network (NCCN) 21st Annual Conference. 2016 Apr 4.
    • The genetic prediction of risk for gynecologic cancers.
    • Randall LM, Pothuri B.
    • Gynecol Oncol. 2016 Apr;141(1):10-6. doi: 10.1016/j.ygyno.2016.03.007.
    • Review
    • Bad Luck Or Bad Genes? Dealing With BRCA And 'A Cancer In The Family'.
    • Terry Gross, Theodora Ross.
    • NPR. Fresh Air. Health. 2016 Mar 14.
    • Genetics of triple-negative breast cancer: Implications for patient care.
    • Afghahi A, Telli ML, Kurian AW.
    • Curr Probl Cancer. 2016 Mar - Aug;40(2-4):130-140. doi: 10.1016/j.currproblcancer.2016.09.007. Epub 2016 Sep 23.
    • Review
    • Genetic testing for hereditary cancer predisposition: BRCA1/2, Lynch syndrome, and beyond.
    • Hall MJ, Obeid EI, Schwartz , Mantia-Smaldone G, Forman AD, Daly MB.
    • Gynecol Oncol. 2016 Mar;140(3):565-74. doi: 10.1016/j.ygyno.2016.01.019. Epub 2016 Jan 23.
    • Review
    • Should you take a genetic test? Here’s what expert counselors advise.
    • Patrick Skerrett
    • STAT. 2016 Feb 12.
    • Cancer predisposition genes: molecular mechanisms and clinical impact on personalized cancer care: examples of Lynch and HBOC syndromes.
    • Wang Q.
    • Acta Pharmacol Sin. 2016 Feb;37(2):143-9. doi: 10.1038/aps.2015.89. Epub 2015 Nov 30.
    • [Hereditary Breast and Ovarian Cancer--From the Gynecological Viewpoint].
    • Ohsumi S.
    • Gan To Kagaku Ryoho. 2016 Feb;43(2):189-92.
    • [Article in Japanese]
    • Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 2.2015.
    • Daly MB, Pilarski R, Axilbund JE, Berry M, Buys SS, Crawford B, Farmer M, Friedman S, Garber JE, Khan S, Klein C, Kohlmann W, Kurian A, Litton JK, Madlensky L, Marcom PK, Merajver SD, Offit K, Pal T, Rana H, Reiser G, Robson ME, Shannon KM, Swisher E, Voian NC, Weitzel JN, Whelan A, Wick MJ, Wiesner GL, Dwyer M, Kumar R, Darlow S.
    • J Natl Compr Canc Netw. 2016 Feb;14(2):153-62.

    Comments on NSGC Discussion Forum Cancer SIG

    Subject: NCCN High-Risk Breast-Ovarian Guidelines 1.2016

    • Breast Cancer Genetic Counseling: A Surgeon's Perspective.
    • Agnese DM, Pollock RE.
    • Front Surg. 2016 Jan 28;3:4. doi: 10.3389/fsurg.2016.00004. eCollection 2016.
    • Expert and Advocacy Group Consensus Findings on the Horizon of Public Health Genetic Testing.
    • Modell SM, Greendale K, Citrin T, Kardia SL.
    • Healthcare (Basel). 2016 Jan 27;4(1). pii: E14. doi: 10.3390/healthcare4010014.
    • Precision medicine in heritable cancer: when somatic tumour testing and germline mutations meet.
    • Ngeow J, Eng C.
    • NPJ Genom Med. 2016 Jan 13;1:15006. doi: 10.1038/npjgenmed.2015.6. eCollection 2016.
    • Hereditary Cancer: Example of a Public Health Approach to Ensure Population Health Benefits of Genetic Medicine.
    • Cragun D, Lewis C, Camperlengo L, Pal T.
    • Healthcare (Basel). 2016 Jan 8;4(1). pii: E6. doi: 10.3390/healthcare4010006.
    • Women's Health Issues for BRCA Mutation Carriers.
    • Sabatini ME, Ellisen LW.
    • Am Soc Clin Oncol Educ Book. 2016;35:14-17. doi: 10.14694/EDBK_100001.

    Comments from NSGC Discussion Forum Cancer SIG

    Subject: hormonal birth control with ATM mutations?

    • Breast Cancer in Africa: Limitations and Opportunities for Application of Genomic Medicine.
    • Silverstein A, Sood R, Costas-Chavarri A.
    • Int J Breast Cancer. 2016;2016:4792865. doi: 10.1155/2016/4792865. Epub 2016 Jun 16.
    • 2016 Genetics Toolkit
    • Society of Gynecologic Oncology
    • Society of Gynecologic Oncology. 2016.

    News: New Toolkit Can Help Debunk Myths About Genetic Testing for Gynecologic Cancer. (Cure)

    • Ovarialcancer är på många sätt en heterogen sjukdom.
    • Malander S, Hjerpe E, Carlson J, Borg Å.
    • Lakartidningen. 2015 Dec 8;112. pii: DIUR.
    • Genetic Testing: What It Means for You and Your Family.
    • Ora Gordon.
    • Everyday Health. 2015 Dec 2.
    • [Hereditary Breast and Ovarian Cancer Syndrome].
    • Petráková K, Palácová M, Schneiderová M, Standara M.
    • Klin Onkol. 2015 Winter;29 Suppl 1:14-21.
    • Review, [Article in Czech]
    • SEOM clinical guidelines in Hereditary Breast and ovarian cancer.
    • Llort G, Chirivella I, Morales R, Serrano R, Sanchez AB, Teulé A, Lastra E, Brunet J, Balmaña J, Graña B; SEOM Hereditary Cancer Working Group.
    • Clin Transl Oncol. 2015 Dec;17(12):956-61. doi: 10.1007/s12094-015-1435-3. Epub 2015 Dec 15.
    • Epidemiology of Patients with Ovarian Cancer with and Without a BRCA1/2 Mutation.
    • Weiderpass E, Tyczynski JE.
    • Mol Diagn Ther. 2015 Dec;19(6):351-64. doi: 10.1007/s40291-015-0168-x.
    • Hereditary Cancer, Insurance, and Your Legal Rights.
    • Anya Prince.
    • FORCE. Be Empowered Webinars. 2015 Nov 18.
    • Discussion: The Next Big Things in the BRCA World.
    • [No author given].
    • My Gene Counsel. 2015 Nov 4.
    • Genital Cancers in Women: Ovarian Cancer.
    • Kuznia AL, Roett MA.
    • FP Essent. 2015 Nov;438:24-30.
    • The Activities and Impact of State Programs to Address Hereditary Breast and Ovarian Cancer, 2011-2014.
    • Trivers KF, Rodriguez JL, Cox SL, Crane BE, Duquette D.
    • Healthcare (Basel). 2015 Oct 15;3(4):948-63. doi: 10.3390/healthcare3040948.
    • Breast Cancer Risk: What Women – and Men – Need to Know.
    • Joy Larsen Haidle.
    • NSGC Blog. 2015 Oct 1.
    • Ovarian cancer: Ensuring early diagnosis.
    • Slatnik CL, Duff E.
    • Nurse Pract. 2015 Sep 13;40(9):47-54. doi: 10.1097/01.NPR.0000450742.00077.a2.
    • Hereditary Breast Cancer Syndromes: Molecular Pathogenesis and Diagnostics.
    • Vos S, Van der Groep P, Van der Wall E, Van Diest PJ.
    • eLS. John Wiley & Sons Ltd, Chichester. http://www.els.net. doi: 10.1002/9780470015902.a0005375. 2015 Sep.
    • Review
    • Hereditary breast cancer: an update on risk assessment and genetic testing in 2015.
    • Stuckey AR, Onstad MA.
    • Am J Obstet Gynecol. 2015 Aug;213(2):161-5. doi: 10.1016/j.ajog.2015.03.003. Epub 2015 Mar 3.
    • Review
    • Management of women at high risk of hereditary breast cancer in the Veneto Regional Program for Prevention.
    • Del Sole A, Cinquetti S, Fedato C, Montagna M, Russo F, Sbrogiò LG, Zorzi M.
    • Epidemiol Prev. 2015 Jul-Aug;39(4 Suppl 1):99-101.
    • Breast cancer in women in their thirties (2007-2013): A retrospective review.
    • Arleo EK, Reichman M, Dashevsky BZ, Babagbemi K, Drotman M.
    • Breast Dis. 2015 Jun 1;35(2):87-93. doi: 10.3233/BD-150400.
    • Breast Cancer Risk Gene Discovery: Opportunities and Challenges.
    • Fabienne Lesueur.
    • Current Genetic Medicine Reports 3(2):8-91. 2015 Jun.
    • Review
    • Committee opinion no. 634: Hereditary cancer syndromes and risk assessment.
    • [No authors listed]
    • Obstet Gynecol. 2015 Jun;125(6):1538-43. doi: 10.1097/01.AOG.0000466373.71146.51.

    Press: ACOG Issues Guidelines for Hereditary Cancer Screening. (Medscape Oncology)

    • Gene analysis techniques and susceptibility gene discovery in non-BRCA1/BRCA2 familial breast cancer.
    • Aloraifi F, Boland MR, Green AJ, Geraghty JG.
    • Surg Oncol. 2015 Jun;24(2):100-9. doi: 10.1016/j.suronc.2015.04.003. Epub 2015 Apr 13.
    • Review
    • Two Women, Two Results: The Agonizing Wait for Cancer Gene Tests.
    • [No author given]
    • NBC Nightly News. 2015 May 19.
    • Mary-Claire King on Inherited Breast/Ovarian Cancer.
    • Dan Koboldt.
    • MassGenomics. 2015 May 14.
    • The Consequences of a BRCA Mutation in Women.
    • Famorca-Tran J, Roux G.
    • J Adv Pract Oncol. 2015 May-Jun;6(3):194-210. Epub 2015 May 1.
    • Genetic tests to identify risk for breast cancer.
    • Lynch JA, Venne V, Berse B.
    • Semin Oncol Nurs. 2015 May;31(2):100-7. doi: 10.1016/j.soncn.2015.02.007. Epub 2015 Feb 26.
    • Review
    • With BRCA genetic testing on rise, insurers balk.
    • Marie McCullough.
    • Philly.com. 2015 Apr 19.
    • 20 Years Since BRCA2: Where Are We Now in Cancer Screening?
    • Eric J. Topol, Nazneen Rahman.
    • Medscape, Eric Topol on Medscape, Medscape One-on-One. 2015 Apr 13.
    • Discussion: Sex After Oophorectomy, Hysterectomy.
    • Mel Majoros, Ellen T. Matloff, Amy Byer Shainman, Georgia Hurst.
    • My Gene Counsel / The Cancer Warrior. 2015 May 5.
    • Angelina Jolie's message was 'choose what's right for you,' and experts agree.
    • Christine Mai-Duc
    • LA Times, 2015 Mar 24.
    • The 2014 Society of Surgical Oncology Susan G. Komen for the Cure Symposium: triple-negative breast cancer.
    • Newman LA, Reis-Filho JS, Morrow M, Carey LA, King TA.
    • Ann Surg Oncol. 2015 Mar;22(3):874-82. doi: 10.1245/s10434-014-4279-0. Epub 2014 Dec 20.
    • Review
    • Personalized assessment and management of women at risk for breast cancer in North America.
    • Pruthi S, Heisey R, Bevers T.
    • Womens Health (Lond Engl). 2015 Mar;11(2):213-23; quiz 223-4. doi: 10.2217/whe.14.79.
    • Breast cancer prevention.
    • Euhus DM, Diaz J.
    • Breast J. 2015 Jan-Feb;21(1):76-81. doi: 10.1111/tbj.12352. Epub 2014 Nov 20.
    • Breast Cancer Susceptibility Genes.
    • Apostolou P, Vratimos A, Fostira F.
    • eLS. 2015 Jan. doi: 10.1002/9780470015902.a0025847.
    • Review
    • Hereditary breast cancer syndromes and genetic testing.
    • Rich TA, Woodson AH, Litton J, Arun B.
    • J Surg Oncol. 2015 Jan;111(1):66-80. doi: 10.1002/jso.23791. Epub 2014 Nov 7.
    • Review
    • Hereditary Ovarian Cancer: Not Only BRCA 1 and 2 Genes.
    • Toss A, Tomasello C, Razzaboni E, Contu G, Grandi G, Cagnacci A, Schilder RJ, Cortesi L.
    • Biomed Res Int. 2015;2015:341723. Epub 2015 May 17.
    • [Triple Negative Breast Cancer].
    • Navrátil J, Fabian P, Palácová M, Petráková K, Vyzula R, Svoboda M.
    • Klin Onkol. 2015;28(6):405-15.
    • Review, [Article in Czech]
    • Unknown significance.
    • Couzin-Frankel J.
    • Science. 2014 Dec 5;346(6214):1167-70. doi: 10.1126/science.346.6214.1167.

    Press: Feature: Peering into my genome (Science)

    • The molecular genetics of hereditary and sporadic ovarian cancer: implications for the future.
    • Al Bakir M, Gabra H.
    • Br Med Bull. 2014 Dec;112(1):57-69. doi: 10.1093/bmb/ldu034.
    • Breast Cancer in Adolescent and Young Adult Women.
    • Gewefel H, Salhia B.
    • Clin Breast Cancer. 2014 Dec;14(6):390-395. doi: 10.1016/j.clbc.2014.06.002. Epub 2014 Jun 23.
    • Review
    • Breast cancer genes: looking for BRACA's lost brother.
    • Cornejo-Moreno BA, Uribe-Escamilla D, Salamanca-Gómez F.
    • Isr Med Assoc J. 2014 Dec;16(12):787-92.
    • BRCA genetic testing: State of the science.
    • Kelly PA, Connors LM.
    • Nurse Pract. 2014 Nov 16;39(11):9. doi: 10.1097/01.NPR.0000456025.48460.c5.
    • Letter, Comment

    Review:

    Genetic testing for BRCA1 and BRCA2 genes.

    • Hereditary breast and ovarian cancer syndrome: Considering the complexities.
    • Senter L.
    • Curr Probl Cancer. 2014 Nov-Dec;38(6):226-34. doi: 10.1016/j.currproblcancer.2014.10.003. Epub 2014 Oct 31.
    • Issues of concern in risk assessment, genetic counseling, and genetic testing of younger breast cancer patients in Japan.
    • Bando H.
    • Breast Cancer. 2014 Nov;21(6):656-63. doi: 10.1007/s12282-013-0477-z. Epub 2013 Jun 11.
    • [Current Clinical Issues and Recent Trends in Hereditary Breast and Ovarian Cancer in Japan-Genetic Testing for HBOC and Risk-Reducing Surgery].
    • Arai M, Iwase T, Takazawa Y, Takeshima N.
    • Gan To Kagaku Ryoho. 2014 Nov;41(11):1333-9.
    • Review, [Article in Japanese]
    • 20 Years After BRCA: What We’ve Learned About Genetics and Breast Cancer
    • [No author given]
    • Dana-Farber Cancer Institute, 2014 Oct 31
    • Familial breast cancer
    • Helen Hanson
    • GP Onlne, 2014 Oct 24
    • Decoding Breast Cancer Risk: BRCA and Beyond.
    • Lidia Schapira, Leif W. Ellisen.
    • Medscape Oncology, 2014 Oct 16.
    • Hereditary breast cancer: clinical, pathological and molecular characteristics.
    • Larsen MJ, Thomassen M, Gerdes AM, Kruse TA.
    • Breast Cancer (Auckl). 2014 Oct 15;8:145-55. doi: 10.4137/BCBCR.S18715. eCollection 2014.
    • Genetics and BRCA in Primary Care.
    • Katherine Kolor.
    • Medscape Oncology, CDC Expert Commentary, 2014 Oct 13.
    • Natural history of ovarian cancer.
    • Vargas AN.
    • Ecancermedicalscience. 2014 Sep 25;8:465. doi: 10.3332/ecancer.2014.465. eCollection 2014.
    • Pathogenesis, prevention, diagnosis and treatment of breast cancer.
    • Shah R, Rosso K, Nathanson SD.
    • World J Clin Oncol. 2014 Aug 10;5(3):283-98. doi: 10.5306/wjco.v5.i3.283.
    • Genetic testing and familial implications in breast-ovarian cancer families.
    • Oosterwijk JC, de Vries J, Mourits MJ, de Bock GH.
    • Maturitas. 2014 Aug;78(4):252-257. doi: 10.1016/j.maturitas.2014.05.002. Epub 2014 May 9.
    • Review
    • The Role of Testing for BRCA1 and BRCA2 Mutations in Cancer Prevention.
    • McCarthy AM, Armstrong K.
    • JAMA Intern Med. 2014 Jul 1;174(7):1023-4. doi: 10.1001/jamainternmed.2014.1322.
    • AGO Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer: Update 2014.
    • Liedtke C, Thill M, Hanf V, Schütz F; AGO Breast Committee.
    • Breast Care (Basel). 2014 Jul;9(3):189-200. doi: 10.1159/000363591.
    • Personalized therapy for breast cancer.
    • De Abreu FB, Schwartz GN, Wells WA, Tsongalis GJ.
    • Clin Genet. 2014 Jul;86(1):62-7. doi: 10.1111/cge.12381. Epub 2014 Apr 9.
    • Family Cancer Syndromes.
    • [No author given]
    • Cancer.org, Last revised 2014 Jun 25.
    • Genetic testing for BRCA1 and BRCA2 genes.
    • Kessenich CR, Bacher K, Moore PA.
    • Nurse Pract. 2014 Jun 15;39(6):8-10. doi: 10.1097/01.NPR.0000446876.99650.eb.
    • Review

    Comment, Letter:

    BRCA genetic testing: State of the science.

    • [Breast cancer update].
    • Armuss A.
    • Versicherungsmedizin. 2014 Jun 1;66(2):68-71.
    • [Article in German]
    • An update on breast cancer screening and prevention.
    • de la Cruz MS, Sarfaty M, Wender RC.
    • Prim Care. 2014 Jun;41(2):283-306. doi: 10.1016/j.pop.2014.02.006. Epub 2014 Mar 27.
    • Review
    • Risk assessment, genetic counseling, and clinical care for hereditary breast cancer.
    • Powers J, Stopfer JE.
    • J Obstet Gynecol Neonatal Nurs. 2014 May-Jun;43(3):361-73. doi: 10.1111/1552-6909.12304. Epub 2014 Apr 1.
    • Review
    • Ovarian Cancer 101 for the Newly Diagnosed.
    • Ilana Cass.
    • FORCE. Be Empowered Webinars. 2014 Apr 11.
    • Two Decades After BRCA: Setting Paradigms in Personalized Cancer Care and Prevention.
    • Couch FJ, Nathanson KL, Offit K.
    • Science. 2014 Mar 28;343(6178):1466-70. doi: 10.1126/science.1251827.
    • Editorial / Commentary
    • Newly Diagnosed with Breast Cancer: What You Need to Know.
    • Melinda Telli.
    • FORCE. Be Empowered Webinars. 2014 Mar 26.
    • Hereditary gynecologic cancers.
    • Mutch D, Denny L, Quinn M; FIGO Committee on Gynecologic Oncology.
    • Int J Gynaecol Obstet. 2014 Mar;124(3):189-92. doi: 10.1016/j.ijgo.2013.12.001. Epub 2013 Dec 21.
    • Practice Guideline
    • Clinical cancer genetics. Part 2: Breast.
    • Pollock J, Welsh JS.
    • Am J Clin Oncol. 2014 Feb;37(1):86-9. doi: 10.1097/COC.0b013e31823fe657.
    • Review
    • The breast cancer susceptibility genes (BRCA) in breast and ovarian cancers.
    • Paul A, Paul S.
    • Front Biosci (Landmark Ed). 2014 Jan 1;19:605-18.
    • Breast cancer genetics: 20 years later.
    • Lubinski J.
    • Clin Genet. 2014 Jan;85(1):5-6. doi: 10.1111/cge.12293. Epub 2013 Nov 18.
    • Editorial / Commentary
    • BRCA-associated ovarian cancer: from molecular genetics to risk management.
    • Girolimetti G, Perrone AM, Santini D, Barbieri E, Guerra F, Ferrari S, Zamagni C, De Iaco P, Gasparre G, Turchetti D.
    • Biomed Res Int. 2014;2014:787143. doi: 10.1155/2014/787143. Epub 2014 Jul 22.
    • Identification, Evaluation, and Treatment of Patients with Hereditary Cancer Risk within the United States.
    • Cragun D, Pal T.
    • ISRN Oncol. 2013 Dec 22;2013:260847. doi: 10.1155/2013/260847. eCollection 2013.
    • Common breast cancer risk variants in the post-COGS era: a comprehensive review.
    • Maxwell KN, Nathanson KL.
    • Breast Cancer Res. 2013 Dec 20;15(6):212. doi: 10.1186/bcr3591.
    • Increase in breast cancer gene screening: the Angelina Jolie effect.
    • Deborah Kotz.
    • Boston Globe. 2013 Dec 3.
    • [Personalized medicine and breast cancer: anticipatory medicine, prognostic evaluation and therapeutic targeting].
    • Gonçalves A, Moretta J, Eisinger F, Bertucci F.
    • Bull Cancer. 2013 Dec;100(12):1295-310. doi: 10.1684/bdc.2013.1856.
    • Review, [Article in French]
    • Ask Well: Genetic Testing for Breast Cancer.
    • Roni Caryn Rabin.
    • New York Times. Ask Well. 2013 Nov 27.
    • My Cancer Story, My Genes, My Information.
    • Joanna Rudnick.
    • Huffington Post. The Blog. 2013 Nov 19.
    • Pros and cons of screening for BRCA mutations.
    • Howard-McNatt M.
    • N C Med J. 2013 Nov-Dec;74(6):489-90.
    • Hereditary breast and ovarian cancer: lessening the burden.
    • Muggia F, Tommasi S, Lynch H, Paradiso A.
    • Ann Oncol. 2013 Nov;24 Suppl 8:viii5-viii6.
    • Hereditary ovarian and breast cancer: what have we learned?
    • Lynch HT, Snyder C, Casey MJ.
    • Ann Oncol. 2013 Nov;24 Suppl 8:viii83-viii95. doi: 10.1093/annonc/mdt313.
    • Breast cancer in adolescents and young adults: a review with a focus on biology.
    • Tichy JR, Lim E, Anders CK.
    • J Natl Compr Canc Netw. 2013 Sep 1;11(9):1060-9.
    • Review
    • Hereditary breast/ovarian cancer syndrome: a primer for obstetricians/gynecologists.
    • Meaney-Delman D, Bellcross CA.
    • Obstet Gynecol Clin North Am. 2013 Sep;40(3):475-512. doi: 10.1016/j.ogc.2013.05.009. Epub 2013 Jul 30.
    • Review
    • Hereditary breast and ovarian cancer susceptibility genes (Review).
    • Kobayashi H, Ohno S, Sasaki Y, Matsuura M.
    • Oncol Rep. 2013 Sep;30(3):1019-29. doi: 10.3892/or.2013.2541. Epub 2013 Jun 19.
    • Evidence is evidence: an interview with Mary-Claire King. Interviewed by Jane Gitschier.
    • King MC.
    • PLoS Genet. [2013 Sep;]9(9):e1003828. doi: 10.1371/journal.pgen.1003828. Epub 2013 Sep 26.
    • Practical aspects of genetic counseling in breast cancer: Lights and shadows.
    • Christinat A, Pagani O.
    • Breast. 2013 Aug;22(4):375-82. doi: 10.1016/j.breast.2013.04.006. Epub 2013 May 11.
    • Review
    • Management of breast cancer in very young women.
    • Freedman RA, Partridge AH.
    • Breast. 2013 Aug;22 Suppl 2:S176-9. doi: 10.1016/j.breast.2013.07.034.
    • Review
    • In brief: BRCA1 and BRCA2.
    • Foulkes WD, Shuen AY.
    • J Pathol. 2013 Aug;230(4):347-9. doi: 10.1002/path.4205.
    • Review
    • Outsmart Your Genes - Understanding BRCA1/2 Cancer Risk.
    • Huma Q. Rana.
    • Dana-Farber Cancer Institute. 2013 Jul 24.
    • Establishing a program for individuals at high risk for breast cancer.
    • Cadiz F, Kuerer HM, Puga J, Camacho J, Cunill E, Arun B.
    • J Cancer. 2013 Jul 1;4(5):433-46. doi: 10.7150/jca.6481. Print 2013.
    • From integrative genomics to therapeutic targets.
    • Natrajan R, Wilkerson P.
    • Cancer Res. 2013 Jun 15;73(12):3483-8. doi: 10.1158/0008-5472.CAN-12-4717. Epub 2013 Jun 5.
    • Breast cancer genes: beyond BRCA1 and BRCA2.
    • Filippini SE, Vega A.
    • Front Biosci (Landmark Ed). 2013 Jun 1;18:1358-72.
    • Familial Breast Cancer: Classification and Care of People at Risk of Familial Breast Cancer and Management of Breast Cancer and Related Risks in People with a Family History of Breast Cancer.
    • [No author given]
    • National Collaborating Centre for Cancer (UK). 2013 Jun.
    • Breast cancer in the young: role of the geneticist.
    • Woodson AH, Profato JL, Muse KI, Litton JK.
    • J Thorac Dis. 2013 Jun;5(Suppl 1):S19-26. doi: 10.3978/j.issn.2072-1439.2013.04.13.
    • Familial breast cancer (CG164).
    • [No author given]
    • National Institute for Health and Care Excellence. 2013 Jun.
    • BRCA Choices Not Affordable for Many US Women.
    • Roxanne Nelson.
    • Medscape Medical News. Oncology. 2013 May 23.
    • Angelina Jolie’s double mastectomy highlights tough decisions on genetic screening.
    • Deborah Kotz.
    • Boston Globe. 2013 May 14.
    • Genetic Counseling Can Help Women At Risk For Breast Cancer.
    • Melissa Block, Audie Cornish.
    • NPR. All Things Considered. 2013 May 14.
    • Familial Breast Cancer: Genetic Testing.
    • Alabek ML, Farley MN.
    • eLS. John Wiley & Sons Ltd, Chichester. doi: 10.1002/9780470015902.a0005634.pub2. 2013 May.
    • Review
    • An international comparison of male and female breast cancer incidence rates.
    • Ly D, Forman D, Ferlay J, Brinton LA, Cook MB.
    • Int J Cancer. 2013 Apr 15;132(8):1918-26. doi: 10.1002/ijc.27841. Epub 2012 Oct 12.
    • Opportunities for public health communication, intervention, and future research on breast cancer in younger women.
    • Buchanan N, Roland KB, Rodriguez JL, Miller JW, Fairley T.
    • J Womens Health (Larchmt). 2013 Apr;22(4):293-8. doi: 10.1089/jwh.2012.4239. Epub 2013 Mar 20.
    • iCOGS collection provides a collaborative model.
    • Bahcall OG.
    • Nat Genet. 2013 Apr;45(4):343. doi: 10.1038/ng.2592.
    • Introductory article

    Blog post: 74 new susceptibility genes found for breast, ovarian and prostate cancer. (Nature Medicine | Spoonful of Medicine)

    • Turning of COGS moves forward findings for hormonally mediated cancers.
    • Sakoda LC, Jorgenson E, Witte JS.
    • Nat Genet. 2013 Apr;45(4):345-8. doi: 10.1038/ng.2587.
    • Introductory article
    • Public health implications from COGS and potential for risk stratification and screening.
    • Burton H, Chowdhury S, Dent T, Hall A, Pashayan N, Pharoah P.
    • Nat Genet. 2013 Apr;45(4):349-51. doi: 10.1038/ng.2582.
    • Introductory article, Commentary

    Press: New Genetic Findings Should Revolutionize Cancer Screening. (Medscape Oncology)

    News: Our commentary in new Nature Genetics special issue. (PHG Foundation)

    • Genetic predisposition syndromes and their management.
    • Euhus DM, Robinson L.
    • Surg Clin North Am. 2013 Apr;93(2):341-62. doi: 10.1016/j.suc.2013.01.005. Epub 2013 Feb 11.
    • Review
    • Miscellaneous syndromes and their management: occult breast cancer, breast cancer in pregnancy, male breast cancer, surgery in stage IV disease.
    • Colfry AJ 3rd.
    • Surg Clin North Am. 2013 Apr;93(2):519-31. doi: 10.1016/j.suc.2012.12.003. Epub 2013 Feb 7.
    • Review
    • [New genetic tests and their clinical utility for cancer screening].
    • Probst-Hensch NM, Brand A.
    • Ther Umsch. 2013 Apr;70(4):251-4; discussion 255-6. doi: 10.1024/0040-5930/a000397.
    • Review, [Article in German]
    • Management of genetic syndromes predisposing to gynecologic cancers.
    • Miesfeldt S, Lamb A, Duarte C.
    • Curr Treat Options Oncol. 2013 Mar;14(1):34-50. doi: 10.1007/s11864-012-0215-3.
    • Review
    • Genetics of Susceptibility to Sporadic Ovarian Cancer.
    • Katabathina VS, Prasad SR.
    • eLS. John Wiley & Sons Ltd, Chichester. http://www.els.net. doi: 10.1002/9780470015902.a0023853. 2013 Feb.
    • BRCA1 and Its Network of Interacting Partners.
    • Christou CM, Kyriacou K.
    • Biology (Basel). 2013 Jan 2;2(1):40-63. doi: 10.3390/biology2010040.
    • Hereditary gynaecological malignancies: advances in screening and treatment.
    • Folkins AK, Longacre TA.
    • Histopathology. 2013 Jan;62(1):2-30. doi: 10.1111/his.12028.
    • Review
    • Ovarian cancer genome.
    • Imyanitov EN.
    • Methods Mol Biol. 2013;1049:3-7. doi: 10.1007/978-1-62703-547-7_1.
    • Review
    • An overview of hereditary breast and ovarian cancer syndrome.
    • Smith EC.
    • J Midwifery Womens Health. 2012 Nov-Dec;57(6):577-84. doi: 10.1111/j.1542-2011.2012.00199.x. Epub 2012 Oct 10.
    • Review
    • Family history and breast cancer.
    • Carroll JC, Heisey R, Warner E.
    • CMAJ. 2012 Sep 4;184(12):1391. doi: 10.1503/cmaj.111670. Epub 2012 Jan 30.
    • [Women with high risk of breast cancer.More bright spots than shadows and many dark spots].
    • Vázquez Caruncho M.
    • Radiologia. 2012 Sep-Oct;54(5):462-4. doi: 10.1016/j.rx.2011.10.004. Epub 2012 Jan 28.
    • [Familial breast cancer and hereditary breast cancer].
    • Masuoka H, Mikami T, Yamazaki K, Shimokawara I, Asaishi K.
    • Nihon Rinsho. 2012 Sep;70 Suppl 7:55-8.
    • [Article in Japanese]
    • [Genetic diagnosis of familial breast cancer].
    • Matsuzaki M, Katagata N, Nomizu T.
    • Nihon Rinsho. 2012 Sep;70 Suppl 7:238-42.
    • [Article in Japanese]
    • Genetics of breast cancer: contribution of BRCA1/2 genes alterations to hereditary predisposition.
    • Branković-Magić M, Dobricić J, Krivokuća A.
    • Vojnosanit Pregl. 2012 Aug;69(8):700-6.
    • Genetic testing by cancer site: breast.
    • Shannon KM, Chittenden A.
    • Cancer J. 2012 Jul-Aug;18(4):310-9. doi: 10.1097/PPO.0b013e318260946f.
    • Review
    • Genetic testing by cancer site: ovary.
    • Weissman SM, Weiss SM, Newlin AC.
    • Cancer J. 2012 Jul-Aug;18(4):320-7. doi: 10.1097/PPO.0b013e31826246c2.
    • Review
    • Managing patients at high risk for hereditary breast cancer: a guide for the practicing physician.
    • Cusack JC Jr, Hughes KS.
    • Ann Surg Oncol. 2012 Jun;19(6):1721-2. doi: 10.1245/s10434-012-2255-0.
    • Hereditary gynecologic cancers: risk assessment, counseling, testing and management.
    • Ballinger LL.
    • Obstet Gynecol Clin North Am. 2012 Jun;39(2):165-81. doi: 10.1016/j.ogc.2012.02.006.
    • Review
    • Young women with breast cancer genes face tough choices.
    • Collier R.
    • CMAJ. 2012 May 15;184(8):E401-2. doi: 10.1503/cmaj.109-4168. Epub 2012 Apr 16.
    • [Hereditary forms of ovarian cancer].
    • de Pauw A, Jolissaint L, Fréneaux P, Rouleau E, Stoppa-Lyonnet D, Buecher B.
    • Bull Cancer. 2012 Apr 1;99(4):453-62. doi: 10.1684/bdc.2012.1544.
    • Review, [Article in French]
    • Translational advances regarding hereditary breast cancer syndromes.
    • Gage M, Wattendorf D, Henry LR.
    • J Surg Oncol. 2012 Apr 1;105(5):444-51. doi: 10.1002/jso.21856.
    • Review
    • Minireview: human ovarian cancer: biology, current management, and paths to personalizing therapy.
    • Romero I, Bast RC Jr.
    • Endocrinology. 2012 Apr;153(4):1593-602. doi: 10.1210/en.2011-2123. Epub 2012 Mar 13.
    • [The clinical study of familial breast cancer - now and the problems].
    • Nomizu T, Matsuzaki M, Katagata N, Watanabe F, Akama Y.
    • Gan To Kagaku Ryoho. 2012 Apr;39(4):502-5.
    • [Article in Japanese]
    • [Clinical aspects of familial ovarian cancer - current status and issues in Japan].
    • Sekine M, Yoshihara K, Tanaka K.
    • Gan To Kagaku Ryoho. 2012 Apr;39(4):506-11.
    • [Article in Japanese]
    • Hereditary breast and ovarian cancer.
    • Barks P, Goldgar C.
    • JAAPA. 2012 Mar;25(3):63-5.
    • Review
    • Physician data query (PDQ®) update.
    • [No authors listed]
    • J Natl Cancer Inst. 2012 Feb 8;104(3):176. doi: 10.1093/jnci/djs025. Epub 2012 Jan 23.
    • Integrating breast cancer genetics into clinical practice.
    • Mukherjee A, Rakha EA.
    • Womens Health (Lond Engl). 2012 Jan;8(1):99-112. doi: 10.2217/whe.11.81.
    • Review